• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Undergraduate
 

Undergraduate

on

  • 1,375 views

 

Statistics

Views

Total Views
1,375
Views on SlideShare
1,375
Embed Views
0

Actions

Likes
0
Downloads
4
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Undergraduate Undergraduate Document Transcript

    • CURRICULUM VITAE PROFESSOR ABDALLAH S. DAAR A. BIOGRAPHICAL INFORMATION 1. Address Program on Life Sciences, Ethics and Policy McLaughlin-Rotman Centre for Global Health University Health Network and University of Toronto 101 College Street, South Tower, Suite 406 Toronto, Ontario, M5G 1L7, CANADA Tel: 416-673-6573 Fax: 416-352-1606 E-mail: a.daar@utoronto.ca Website: www.mrcglobal.org 2. Medical Schools Undergraduate • St. Thomas’ Hospital Medical School, University of London, London, England (1972-1973) • Makerere University, Kampala, Uganda (1968-1972) Postgraduate • Oxford University (1976-1984) 3. Degrees /Qualifications/Fellowships • F.R.S.C (2006) • FRCS (C) (2001) • FRCP (Lond.). (1995) • D. Phil (Oxon). (1983) Nuffield Department of Surgery, Faculty of Medicine, Oxford University/Wolfson College (Immunology) • FRCSEd. (1978) Nuffield Department of Surgery, Oxford University/Royal College of Surgeons of Edinburgh • FRCS. (1977) Nuffield Deptartment of Surgery, Oxford University/Royal College of Surgeons • MRCP (UK). (1977) Nuffield Department of Surgery, Oxford University/Royal College of Physicians of London • LRCP (Lon.), MRCS (Eng.). (1973)
    • Curriculum Vitae, Daar AS St. Thomas' Hospital Medical School (University of London) (1972-3) & Makerere University, Uganda (1968-72) 4. Licensure • Principal List of the General Medical Council of Great Britain (Registration # 1599132) • Specialist Register (General Surgery) of the The Specialist Authority of the UK Medical Royal Colleges • Ontario College of Physicians and Surgeons College Register No. 78603 • Maintenance of Certification Program at The Royal College of Physicians and Surgeons of Canada (2002-2007) 5. Employment Current, Academic • Professor of Public Health Sciences, University of Toronto (2001-) • Professor of Surgery, University of Toronto (2001-) • Senior Scientist and Director, Program on Ethics and Commercialization McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto (2006-) • Senior Scientist and Director of Ethics and Policy, McLaughlin Centre for Molecular Medicine, University of Toronto (2004- ) • Senior Scientist, Research Institute, The Hospital for Sick Children (2002-) • Associate Scientist, Samuel Lunenfeld Research Institute, Mount Sinai Hospital (2002-) • Member, School of Graduate Studies, University of Toronto (2002-) • Member, Institute of Medical Sciences, University of Toronto (2002-) Previous, Academic • Professor and Chairman, Department of Surgery, College of Medicine, Sultan Qaboos University, Oman (1988-98) • Professor, Department of Surgery, College of Medicine, Sultan Qaboos University, Oman (1988-2000) • Co-Director, Canadian Program on Genomics and Global Health, University of Toronto Centre for Bioethics (2001-2007) • Director, University of Toronto Program in Applied Ethics and Biotechnology, University of Toronto Joint Centre for Bioethics (2001-2007) • Visiting Professor, Department of Surgery, University of Toronto (July 1998 - February 1999) • Visiting Professor in Health Policy and Society, Faculty of Law and Joint Centre for Bioethics, University of Toronto (July 1998 - March 1999) [Sabbatical] • Member of Faculty, European College of Transplantation (~1994-97) • Visiting Scholar, Center for Biomedical Ethics, Stanford University (February - June 1998) 2
    • Curriculum Vitae, Daar AS • Member, Foundation Committee/Transitional Council, Faculty of Medicine and Health Sciences, United Arab Emirates University (1985-88) • Founding Director, Emirates Institute for Medical Research, United Arab Emirates (1985-88) • Member, Steering Committee, Faculty of Medicine and Health Sciences, United Arab Emirates University (1985) • Surgical Tutor, Clinical Lecturer, Medical Research Council of Great Britain Training Fellow, Lecturer in charge of lymphoma service, and Fellow in Transplantation, Nuffield Department of Surgery, University of Oxford (1979-84) • Visiting Professor, Department of Anatomy, University of Houston (1975) Previous, Clinical • Senior Consultant Surgeon, University Hospital, Sultan Qaboos University, Oman (1988-2000) • Head of Surgery, Oman Transplant Program (1988-2000) • Chief of Surgery, University Hospital, Sultan Qaboos University, Oman (1988-98) • Senior Consultant Surgeon, The Royal Hospital, Oman (1988-91) • Senior Consultant Surgeon and Head of Clinical Transplant Programme, Mafraq Hospital, United Arab Emirates (1984-87) • Senior Registrar (Clinical component of lecturer position), Nuffield Department of Surgery, John Radcliffe Hospital, Oxford (1979-84) Supervisors: Professor PJ Morris (General, Transplantation and Vascular Surgery), Mr. J. Collin (General and Vascular Surgery), Mr. RMF Wood, Professor Morris and Dr. AH Laing (Lymphoma Surgery), Mr. MJ Britton (Pancreatio- biliary Surgery), Mr. NE Dudley (Paediatric and Endocrine Surgery), Mr. JC Smith (Urology), and [Mr. Gunning (Thoracic)] • Registrar, (Middle Grade) in General Surgery/Urology, Gloucestershire Royal Hospital, Gloucester, UK (1978-79) Supervisors: Mr. MWL Gear, Mr. D Calvert, and Mr. H Thomson • SHO (Surgery), Nuffield Department of Surgery (Churchill Hospital and Radcliffe Infirmary), Oxford (1976-77) Supervisors: Professor PJ Morris, Mr. M Kettlewell, Mr. BJ Britton, and Mr. HW Steer • SHO Accident & Emergency and Demonstrator in Anatomy, St. Thomas' Hospital Medical School, London (1974-75) • House Officer (Intern) Medicine and Surgery, Queen Alexandra Hospital, Cosham, Portsmouth UK (1973-74) 6. Honours • Fellow of The Academy of Sciences for the Developing World (TWAS) (2007-) • Fellow of the Royal Society (Canada) (2006-) • Fellow, Canadian Academy of Health Sciences (2006-) • Fellow, New York Academy of Sciences (1998-) • Senior Fellow, Massey College, University of Toronto (2006-) • Hunterian Professor, Royal College of Surgeons of England (1999) 3
    • Curriculum Vitae, Daar AS • UNESCO Avicenna Prize for Ethics in Science, UNESCO (2005) • Patey Prize of the Surgical Research Society of Great Britain (see details next section) (1981) • Anthony Miller Award for Research Excellence, University of Toronto (2005) • Inaugural Lecturer of The Bourns Lecture in Bioethics at McMaster University (2004) • Best Teacher of the Year Sultan Qaboos University College of Medicine 1989/1990 • Jan Brod Lecturer, University of Oxford (1999) • Ellen Picard Lecturer, Health Law Institute, Faculty of Law, University of Alberta (1999) • Panel of Examiners, Royal College of Surgeons of Edinburgh (1999-2003) • Patron President, 2nd International Congress on Transplantation in Developing Countries, Taiwan (Delayed) (1998) • Distinguished Foundation Visitor, Royal Australasian College of Surgeons (Universties of Auckland, Otago, Sydney and Queensland) (1996) • President, First International Congress on Transplantation in Developing Countries, Singapore (May 1993) • Official world record for performing the youngest cadaveric donor kidney transplant • British Society of Immunology Travelling Award (1983) • International Union of Immunological Societies Travelling Award (1981) • Medical Research Council of Great Britain Delegacy to Triennial Convocation of Nobel Prize winners in medicine/physiology, Lindau, Germany (1981) • Medical Research Council of Great Britain Training Fellowship (1980-83) • University Exhibition (Academic Achievement) (1969-70) Makerere University, Uganda • University Entrance Scholarship (1968), Makerere University, Uganda 7. Research Prizes • Patey Prize: Daar AS, Fabre JW. Demonstration with monoclonal antibodies of an unusual mononuclear cell infiltrate and of normal epithelial membrane antigens in human breast carcinoma. Summer Meeting, Surgical Research Society of Great Britain. Cardiff, Wales, July 1981. Awarded the Patey Prize of the Surgical Research Society of Great Britain for this work. Abstract published in British Journal of Surgery 1981; paper published in Lancet 1981; 8244: 434-8. • Hunterian Professor, Royal College of Surgeons of England (1999) • UNESCO Avicenna Prize for Ethics in Science, UNESCO (2005) • Anthony Miller Award for Research Excellence, University of Toronto (2005) • 2004 Award for Best Clinical Sciences Research Kuwait University 9th Annual Health Sciences Center 4
    • Curriculum Vitae, Daar AS Kehinde EA, Akanji AO, Daar AS, Luqmani Y, Bashir AA, Al Awadi KA. Do differences in age-specific serum adrenal C19 steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians. 8. Professional Affiliations and Activities • Member, International Bioethics Committee, UNESCO (2008-2011) • Visiting Professor, Faculty of Medicine, University of Kuwait (April 2008) • Member, Executive Committee, SciDev.Net Board (2008-) • Member, Executive Committee, Israeli Palestinian Science Organization (IPSO) [2007-] • Member, Executive Committee of the Grand Challenges in Non-Communicable Diseases (October 2007-) • Member, Editorial Board of BMC Medical Genomics (2007-) • Advisor to the United Nations Secretary General’s Office on Biotechnology and Human security (2007-) • Adjunct Member, University Ethics Review Committee, The Aga Khan University (2007-2009) • Trustee, Board of Trustees, SciDev. Net (2007) • Member – International Advisory Committee, International Conference on Medical Ethics, Tehran (2006) • Member, African Union High Level Panel on Modern Biotechnology (2005-) • Member, Executive Committee, The International Human Rights Network of Academies and Scholarly Societies. • Member , Senior Advisory Panel, International Life Sciences Council (2006-) • Member, Peer Review Committee, Chair in Neuroethics, CIHR Institute of Neurosciences, Mental Health and Addiction (2006) • Member – Steering Group of GRaPH-Int (Genome-Based and Population Health International Network (2006) • Member, Research Policy Advisory Committee, Canadian Institutes of Health Research (2006-) • Member, International Scientific Council, Israeli-Palestinian Science Organization (IPSO) (2006-) • Member, Research Management Committee of Stem Cell Network (2006-7) • Executive Council Member, PharmacoGenetics for Every Nation Initiative, Washington University, St. Louis, USA (2006-) • Faculty Associate, Centre for Ethics, University of Toronto (2006-) • Consultant, WHO Roll Back Malaria Program, Geneva (Consultation on WHO Roles and Functions in Achieving RBM Goals and Targets). (Nov. 2005) 5
    • Curriculum Vitae, Daar AS • Member, Scientific Advisory Board, The Centre for Applied Genomics Research Institute, The Hospital for Sick Children, Toronto (2005-) • Member, African Union High-Level Panel on Modern Biotechnology (2005-) • Member, Taskforce on Nanotechnology and Ethics, Division of Ethics of Science and Technology of UNESCO with the World Commission on the Ethics of Scientific Knowledge and Technology (COMTEST) (2005-) • Full member/Principal Investigator, Stem Cell Network, Canada (2005-2007) • Chair, 4th Independent External Review of UNDP/ UNICEF/ World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) (2004-) • Rockefeller Foundation Joint Learning Initiative on "Enhancing Problem-Solving Capacity for Priority Diseases of the Poor." On two working groups (Africa, and Innovation) of “Strategies on Human Resources for Health and Development” (2004-) • Canadian Biotechnology Advisory Committee Expert Working Party on Human Genetic Materials, Intellectual Property and the Health Sector (2004-2006) • College of Reviewers, Canada Research Chairs (2004-) • Member, Expert Advisory Committee on Cells, Tissues and Organs (EAC-CTO), Health Canada (2004-2006) • Member, Canadian Coalition for Global Health Research (CCGHR) (2004-) • Member, Steering Committee, McLaughlin-Rotman Centre for Global Health • Member, McGill Centre for Intellectual Property Policy • Member, Ontario Genomics Institute Ethics GE3LS Committee • Member, Panel of Experts, Human Genetics Programme (HGN), World Health Organization (WHO) (2003) • Member, Program Advisory Committee, Canadian Institutes of Health Research Program on Regenerative Medicine (2002-) • Member, Ethics and Equity Committee, the Royal College of Physicians and Surgeons of Canada (2002-2006) • Member and Ethics Lead, Institute Advisory Board, Institute for Infection and Immunity, Canadian Institutes for Health Research (2001-04) • Member, Advisory Committee, Centre for International Health, University of Toronto (2001-) • Member, Roster of Experts for the Food and Agriculture Organization of the United Nations/World Health Organization Joint Consultations on Foods Derived from Biotechnology (2000-) • Board of Consultants, German Academy of Transplantation Medicine (2000-) • Member, Ethical, Legal, and Social Issues Committee, Human Genome Organization (1999-) • Core Group, Meech Lake International Initiative on Science and Ethics (1999-2000) • Moderator, World Health Organization/ Health Canada Electronic Discussion Group on Xenotransplantation (1999-2000) See report at http://www.oecd.org/dsti/sti/s_t/biotech/xenosite/background.htm 6
    • Curriculum Vitae, Daar AS • Member, Advisory Committee, 5th International Congress on Xenotransplantation, Japan (1999) • Rapporteur, Working Party on Genetic Recombinations, World Health Organization (1998-99); and Author of WHO’s Daar-Mattei Report (At request of Director-General of WHO) • Steering Committee, Executive Course, "Understanding the New World of Health Care -An Intensive Program for Canadian Leaders." Run jointly by the University of Toronto Joseph L. Rotman School of Management and Harvard University (1998) • Member, Ethics Committee, Asian Transplantation Society (1998-2005) • Chairman, WHO Consultation on Xenotransplantation (1997) See report at http://www.who.int/emc-documents/zoonoses/docs/whoemczoo982.pdf • PhD Examiner, University of Sydney (1996) • Member, Taskforce on Organ Transplantation, World Health Organization (1995-96) • Member, Bellagio Taskforce on Transplantation, Bodily Integrity and the International Traffic in Organs (~1994-96) • Member (Hon.), Munich Working Group on the Living Donor (~1996-) • External Examiner in Surgery, Faculty of Medicine and Health Sciences, Arabian Gulf University (Past) • Member, Ethics Committee, The ( International) Transplantation Society (~1992-) • Councillor, Asian Society of Transplantation (~1992-) • Councillor, Middle East Society for Organ Transplantation (past) • Faculty, Einstein Institute for Science, Health and the Courts (EINSHAC) • Faculty, National Judicial Institute, Canada • Member of the Advisory Board of the newly established UNU International Institute for Global Health (UNU-IIGH) in Kuala Lumpur (September 2008) • Invitation to Scientific Programme Committee for HUGO Symposium on Genomics and Ethics, Law and Society (November 2008) Professional Societies • Member, The (International) Transplantation Society • Honorary Life Member, South African Transplantation Society • Member, Transplantation Society of Australia and New Zealand • Member, British Society of Immunology (past) • Member, British Transplantation Society (past) • Member, Society for Organ Sharing (past) Memberships in the Editorial Boards • Editorial Board, Islamic Educational, Scientific and Cultural Organization and Malaysia Biotechnology Information Centre (ISESCO-MABIC) (April 2008) 7
    • Curriculum Vitae, Daar AS • Editorial Board, International Journal of Technology and Globalization (2005-) • Editorial Board, Journal of Genomics, Society and Policy (2005-) • Editorial Board, Journal of Genomic Medicine (2005-) • Editorial Board, Journal of Globalization and Health (2004) • Special Issue Editor on Policy and Ethical Issues in Surgery, World Journal of Surgery • Member, Advisory Board, Journal of Kuwait Medical Association • Member, International Scientific Advisory Board, Transplant Asia (2004-) • Member, Editorial Board, Journal of Experimental and Clinical Transplantation (2003-) • Member, Advisory Board, Bioethics (2000-04) • Member, Editorial Board, World Journal of Surgery (1998-2001) • Member, Advisory Board, Kidney Forum (~1997-) • Member, Advisory Board, Brazilian Transplant Journal (~1997-) • Member, Advisory Board, Transplantation India (~1997-) • Member, Advisory Board, Transplantation in Developing Nations (1997-) • Consulting Editor, Emirates Medical Journal (~1996-) • Member, Advisory Board, Clinical Transplantation Proceedings (~1994-) • Member, Advisory Board, Saudi Bulletin of Transplantation and Kidney Diseases (~1994-) • Editor-in-Chief, Sultan Qaboos Journal of Scientific Research (Medical Sciences) ( Past) Others: • Chair, Education Committee – McLaughlin-Rotman Centre for Global Health Also Reviewer for: Bioethics, Clinical Transplantation Proceedings, Journal of Medical Ethics, Transplant Intenational, Transplantation, Transplantation Proceedings, World Journal of Surgery, Biomedcentral Ethics, American Journal of Transplantation 9. Current Academic Appointments (University of Toronto) University Committees • Member, Decanal Promotions Committee, University of Toronto (2005-) • Member, Director Search Committee, University of Toronto Joint Centre for Bioethics (2005-) • Member , University of Toronto Tribunal (2004-06) • Member, Executive Committee of the Collaborative Program in Bioethics, University of Toronto (2002-) 8
    • Curriculum Vitae, Daar AS • Member, Committee for International Surgery, Office of International Surgery, University of Toronto (2002-) • Member, University of Toronto Joint Centre for Bioethics Management Committee (2002-) • Member, Molecular Medicine Executive Committee, University of Toronto (2001-) • Member, Advisory Committee, Centre for International Health, University of Toronto (2001-) • Member, Advisory Committee, Joint Centre for Bioethics, University of Toronto (2001-) Previous (University and Hospital • Chairman, Five-Year Strategic Planning Committee (Raising Our Sights), Sultan Qaboos University, College of Medicine (1999-2001) • Member, Medical Research and Ethics Committee, Sultan Qaboos University (1999-2000) • Editor-in-Chief, Sultan Qaboos University Journal of Scientific Research (Medical Sciences) (~1997-2000) • Deputy Chairman, Oman National Renal Failure and Transplantation Committee (~1997-2000) • Member, Scientific Publications Committee, Sultan Qaboos University • Member, Oman Medical Specialties Board, Sultan Qaboos University (1996-98) • Member, Joint Health Committee, Sultan Qaboos University/ Ministry of Health (~1995-98) • Chairman, Medical Advisory Committee, Sultan Qaboos University Hospital (~1993-95; 1999-2000) • Member, Hospital Board, Sultan Qaboos University Hospital (~1993-95; 1999-2000) • Chairman, Clinical Curriculum Committee, Sultan Qaboos University (1990-98) B. ACADEMIC HISTORY I. Research Interests • Ethics and Policy of Science and Technology for global health and economic development. • Harnessing Genomics/Biotechnology to Improve Global Health Equity • Global Health Ethics • Ethics of Cloning/Stem Cells • Ethical, Legal and Social Issues of Regenerative Medicine • Ethical, Legal and Social Issues in Nanotechnology • Ethical, Legal and Social Issues of Pharmacogenomics and Applications to Global Health • Health Policy in Developing Countries • Ethical Issues in Transplantation in Developing Countries • Grand Challenges in addressing health and developmental issues • Accelerating innovation in Science and Technology in Developing Countries 9
    • Curriculum Vitae, Daar AS • Regulatory Challenges in moving toward genomic health II. Research Awards Training Awards Period Granting Agency Title of Grant Amount Role 1989-92 Medical Research Training Fellowship Council of Great Britain Research Grants Period Granting Agency Title of Grant Amount Role 2000-04 Fogarty International U of T MHSc in US $1,193,020 Co-applicant (renewed Center, National International Bioethics in 2004) Institutes of Health 2000-07 Ontario Research Fund U of T Program in Applied $5,620,000 Co-applicant and Ethics and Biotechnology Program Director 2001-05 Genome Canada Canadian Program in $7,200,000 Co-applicant Genomics and Global Health 2002-05 Canadian Institutes for Reconciling growth with $281,802 Co-applicant Health Research ethics: Models of intellectual property protection for biotechnological innovation 2002-04 US Dept. of Energy Representation of $267,000 Collaborator genomics research among Latin American Laymen and Bioethicists 2002-08 Canadian Institutes for Training Program in $1,860,590 Co-Investigator Health Research Regenerative Medicine -Ethics theme co- leader 2002-04 Genome Canada Bridging the Emerging $2,830,006 Co-applicant Genomics Divide 2003-04 Canadian Institutes for Genomics and Global $62,700 Principal Health Research Health: Developing a Investigator Global CIHR Nework to Address Ethical, Policy, and Regulatory Issues 2003-07 Social Sciences and Modeling Agricultural $2,989,500 Co-Investigator Humanities Research Biotechnology Intellectual Council, Initiative on the Property Protection New Economy, Collaborative Research Initiative 2004-06 Canadian Institutes for Ethical Challenges in the $202,850 Co-Principal Health Research Preparedness and Investigator Response for SARS: An Interdisciplinary Research 10
    • Curriculum Vitae, Daar AS Study 2004-06 Canadian Institutes for Authorization and $79,000 Co-Investigator Health Research Databases 2004-06 Canadian Institutes for Compelling Values: $38,807 Co-Investigator Health Research Privacy, Access to Data & Health Research Competition 2005-06 Canadian Institutes for Leveraging Canadian $56,886 Co-investigator Health Research health research through partnerships with developing countries: A study on collaboration in health biotechnology 2005-09 Canadian Institutes for RMEthnet: "Regenerative $1,500,000 Principal Health Research Medicine: Ethical, Investigator Environmental, Economic, Legal and Social Issues Network" 2006-10 Genome Canada Quantum Dot Diagnostics: $9,300,000 for 3 Co-applicant through Simultaneous Genomic of the 4 years Ontario Genomics and Proteomic Profiling of requested Insitute Multiple Pathogens at Point-of-Care 2006-10 Genome Canada Strenthening the Role of $10,200,000 Co-Principal through Ontario Genomics and Global Investigator Genomics Institute Health 2005 Bill and Melinda Gates Summary Report of $179,395 US Co-investigator Foundation Ethical, Social and Cultural Issues Arising in the Grand Challenges for Global Health 2005 Bill and Melinda Gates (Contract) : Review of $36,000 Contractee Foundation Grand Challenges in Global Health projects for Ethical, Social and Cultural Issues 2005-09 Bill and Melinda Gates Ethical, Social, and US$10,000,000 Co-Principal Foundation Cultural Program for the Investigator Grand Challenges in Global Health Initiative 2006-2010 Genome Canada Structural and Functional $22,608,752 Co-investigator Annotation of the Human Approved, (PI: Robert Genome for Disease Study pending final Hegele) details on co- funding 2006-11 Ontario Research Fund From disease gene $14,463,000* Co-Principal mapping to clinical Investigator practice – a provincial 11
    • Curriculum Vitae, Daar AS program in clinical genomics 2005-09 Ontario Research Fund Strengthening the Role of $950,000 Co-Principal Genomics and Global Investigator Health 2006-09 Canadian Institutes of Ethics and pandemic $150,000.00 Co-investigator Health Research planning: Engaging the voices of the public 2008-12 Bill and Melinda Gates Ethical, Social, Cultural 2,992,320 Principal Foundation and Commercialization Investigator (ESC2) Program for Water-Efficient Maize for Africa (WEMA) *my share of this is much smaller and related to GELS work. III. Current Research Projects Program on Life Sciences, Ethics and Policy of McLaughlin-Rotman Centre for Global Health 1. Intellectual Property Modeling Group (see Report by our International Expert Group on Biotechnology, Innovation and Intellectual Property(September 9, 2008). Available at SSRN: http://ssrn.com/abstract=1260099 2. Ethical, Legal and Social Issues in Regenerative Medicine including neuro-RM 3. Ethical, Social and Cultural Program of the Bill and Melinda Gates Foundation – Grand Challenges for Global Health Initiative 4. Science, Technology, Innovation and Foreign Policy: Canada’s Role 5. Ethical, Legal and Social Issues of Quantum Dots-based Diagnostic Platform 6. North-South Collaboration in Health Biotechnology Development 7. South-South Collaboration in Health Biotechnology Development 8. Human Genome Variation and Global Health 9. Biotechnology and Human Security 10. Innovation Systems and Contribution to Health 11. Health Biotechnology Innovation systems of Emerging Economies and Developing Countries 12. Energizing Science and Technology Innovation in Health Biotechnology in Africa 13. Grand Challenges –Chronic Non-Communicable Diseases 14. Grand Challenges for Global Health and Development STUDENTS/RESEARCHERS SUPERVISED OR CO-SUPERVISED PhD Students 12
    • Curriculum Vitae, Daar AS 1. Jeff Nisker: Public Engagement on Genetic Testing Issues through Plays (Primary Supervisor). Successfully defended his thesis in January 2005. 2. Robert Williams: Phenomenology of SARS at a Toronto Hospital (Primary Supervisor). Successfully defended his thesis in June 2007. 3. Robin Hayeems: “Appraisal of Informed Consent and Genetic Databases: An Exploration of the Authorization Model” [Thesis committee member]. Successfully defended her thesis in April 2007. 4. Zahava Rosenberg: Priority Setting for Genomics Technologies [Thesis committee member] 5. Bram de Jonge (Wageningen University and Research Center): Benefit Sharing of Plant Genomics (Supervisory Committee Member) 6. Sara Albader, PhD Student at IMS working under the private Sector team researching the role of the private sector in addressing South Africa's health needs through biotechnology (2006-) [Co-Primary Supervisor]. Successfully converted from MSc to PhD in 2007. 7. Monali Ray. “A Case Study on Canada-India Collaboration in Health Biotechnology”. Successfully converted from MSc to PhD. [Thesis Committee member] 8. Rahim Rezaie. Working on Private-sector health biotech development in the emerging economies of Brazil, India and China. Successfully converted from MSc to PhD in 2007 9. Billie-Jo Hardy. Working under Human Genome Variation Project entitled “Adoption of Genotyping Technologies for Health in India and Economic Sovereignty [Primary Supervisor]. Converting from MSc to PhD on June 3, 2008. 10. Fabio Salamanca-Buentello. PhD Student [Thesis committee member]. 11. Kenneth Simiyu. PhD Student working on the study investigating the role of health biotechnology innovation systems in selected African countries. [Thesis Committee Member] 12. Kadia Petricca. PhD Student working on developing and pilot-testing guidelines for improving priority setting at the meso and macro levels in Ethiopia, Tanzania and Zambia. (Thesis Committee Member 13. Dominique McMahon. Regenerative Medicine innovation in emerging economies: A comparative case study of China, Brazil and India (Co-supervisor) 14. Fabio Salamanca-Buentello: Technology and Road mapping (Thesis Committee Member) MSc Students 1. Marian Adly: Limiting the collateral damage of SARS: Priority-setting and public health crises [Thesis committee member] 2. Pam Kolopack: Issues of Patient Safety and Research Integrity in Innovative Clinical Trials [MSc Primary Supervisor]. Successfully defended her thesis in April 2008. 3. Jocelyn Mackie: Bioscience Business Ethics [Thesis committee member]. Thesis successfully defended in 2004. 4. Andrew Taylor: Developing Policy Options for Canada’s 5% of RD Expenditure Commitment for Development [Thesis committee member]. Successfully defended thesis 2005. 5. Heather Greenwood: Regenerative Medicine for Developing Countries [Primary Supervisor]. Successfully defended thesis in June 2006. 13
    • Curriculum Vitae, Daar AS 6. Fabio Salamanca-Buentello: Nanotechnology for Development [Thesis committee member]. Successfully defended MSc thesis in September 2006. 7. Marion Motari. MSc thesis successfully defended November 2003. Research Assistants/Associates and Post-Doctoral Fellows: 1. Haeli Goertzen [Research Assistant – September 2003-January 2004] 2. Rosario Isasi [Post-doctoral Fellow – 2002-03] 3. Robyn Kennedy [Research Assistant – January-April 2004] 4. Zahra Merali [Post-doctoral Fellow – 2002-03, seconded to WHO; Consultant on PhD thesis, started September 2001, now in law school] 5. Halla Thorsteinsdóttir [Senior Research Associate] 6. Alyna Smith [Research Assistant, seconded to WHO in Geneva, now working with the IP Commission at WHO, Geneva] 7. Charoula Tsamis [Research Assistant 2003-05] 8. Deepa L. Persad (Research Assistant 2003 - October 2005; Program Research Coordinator November 2005 - Present) 9. Archana Bhatt [Research Assistant 2004-05] 10. Uyen Quach [Research Assistant 2003-04] 11. Jason Kuhar [Research Assistant 2004-05] 12. Christina Salmon [Research Assistant 2003-04] 13. Cheryl Cline [Research Assistant/post-doctoral fellow 2003-05] 14. Sarah Frew [Post-doctoral fellow] 15. Tara Acharya [Post-doctoral fellow 2002-03] 16. Christopher McDougal [Research Assistant] 17. Erin Court [Research Assistant] 18. Béatrice Séguin [Post-doctoral fellow] 19. Monali Ray [Research Assistant 2005-2006] 20. Dilnoor Panjwani (Research Assistant 2005 - 2006) 21. Anna Dabu (Research Assistant 2005-2006) 22. Rahim Rezaie (Research Assistant 2005 - Present) 23. Billie-Joe Hardy (Research Assistant 2006) 24. Ronak Shah (Research Assistant May 2007-Present) 25. Maya Maliakkal (Research Assistant April 2007-Present) 26. Mark Messih (Research Assistant – September 2007-Present) 27. Fiona Thomas (Research Assistant – September 2007-Present) 28. Victor Liu (Research Assistant – September 2007- PResent) 29. Natasha Bhogul (Research Assistant – September 2007-Present) 14
    • Curriculum Vitae, Daar AS 30. Sina Zere (Research Assistant January 2008-) 31. May Sanaee (Research Assistant January 2008 -) Past Summer Students: Excluding the 26 graduates that I have taught in our professional MHSc Bioethics Program (See list below) 1. Graeme Bancroft [Summer Student] 2. Isaac Filate [Summer Student, supervised independent study] 3. Jennifer Lam [Supervisor of Senior Research Paper – April 2002-June 2003] 4. Djimms Martinus [Summer Student] 5. Katherine MacDonald [Summer Student] 6. Erin McFadden [Summer Student] 7. Anisa Mnyusiwalla [Summer Student] 8. Martin Tierney [Summer Student] 9. Puja Sahni [Summer Student] 10. Shauna Nast 11. Alex Bite [Summer Student] 12. Leah State [Summer Student] 13. Winnie Siu [Summer Student] 14. Curtis Chin [Summer Student] 15. James Renihan [Summer Student] 16. Ilana Cohen [Summer Student] 17. Susan Dubbin 2006 Summer Students and their Projects 1. Amy Teper - Nanotechnology; WaterEngage 2. Kelsee Stephenson - Nanotechnology; WaterEngage 3. Samina Essajee - Human Genomic Variation 4. Emma Cohen - Grand Challenges in Global Health ESC Program 5. Dilzayn Panjwani - Grand Challenges in Global Health ESC Program 6. Joshua Ramjist - Private Sector Development 7. Jennifer Heys - Private Sector Development 8. Jennifer Chadder - South-South Collaboration 9. Michelle Li - South-South Collaboration 10. Gajen Perry - South-South Collaboration 11. Gunjeet Minhas - OxHA Grand Challenges; WaterEngage 15
    • Curriculum Vitae, Daar AS 2007 Summer Students 1. Howard Choi – ESC Community Engagement 2. Miry Choi – ESC Product Development and MaRS Africa 3. Nidhee Jadeja – Human Genome Variation 4. Michelle Li – South to South Collaboration and Private Sector 5. Miranda Lin – MaRS Africa 6. Kelvin Lui - ESC Public Engagement 7. Christina Melon - South to South Collaboration 8. Mark Messih – Neuro-Regenerative Medicine 9. Jessica Mustachi – Grand Challenges Chronic Non-Communicable Diseases and Working Groups 10. Gabriel Sin – Regenerative Medicine China 11. Fiona Thomas – MaRS Africa 12. Maya Maliakkal – Private Sector 13. Insiya Essajee - Private Sector 14. Josh Ramjist - Private Sector 2008 Summer Students 1. Alexander Lim – Collaborations 2. Don Li – Private Sector 3. Jasmin Fernandez – Product Development 4. Kim Le – Product Development 5. Marilyn Heymann – MaRS Africa 6. Menaka Pulandiran – MaRS Africa 7. Rabia Tahir – Human Genomic Variation 8. Renaud Boulanger – Community Engagement / Advisory Service 9. Michael Kuziw – WEMA / Advisory Service 10. Melinda Treurnicht-Naylor – WEMA / Engage 16
    • Curriculum Vitae, Daar AS Publications 17
    • Curriculum Vitae, Daar AS C. PUBLICATIONS Doctor of Philosophy ( D.Phil) Thesis, Univeristy of Oxford Daar AS. Studies with monoclonal antibodies on the potential clinical value of human cell membrane differentiation antigens. Doctor of Philosophy Degree thesis, University of Oxford, 1982. Books 1. Gough MH, Gear MW, Daar AS. Plain X-Ray Diagnosis of the Acute Abdomen. Oxford: Blackwell Scientific Publishers, 1986. ISBN 0632-01432-6 2. a. Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publishers, 1987. ISBN 0-632-01512-8 b. Daar AS, ed. Mercatori Tumerali nella Pratica Clinica: Concetti ed Applicazioni. (Italian Translation of Tumour Markers in Clinical Practice: Concepts and Applications.) Salerno, 1998. ISBN 0-632-01512-8 3. Gutmann T, Daar AS, Sells RA and Land W, Eds. Ethical, Legal And Social Issues In Organ Transplantation. Munich: PABST Science Publishers, 2004. ISBN 3-89967-017-5 (Europe), ISBN 1-59326-063-6 (USA) 4. Finegold DL, Bensimon CM, Daar AS, Eaton M, Goddard B, Knoppers BM, Mackie JE, Singer PA. BioIndustry Ethics. San Diego: Elsevier Academic Press, 2005. ISBN 0-1236-9370-5 5. Castle D, Cline C, Daar AS, Singer PA, Tsamis C. Science, Society, and the Supermarket- The Opportunities and Challenges of Nutrigenomics. John Wiley and Sons, Inc., November 2006. 176 pp. ISBN: 0-471-77000-0 Forthcoming: 6. Daar AS, Singer PA. From Lab to Village. Double Day Reports in Book Form Reports in Book Form 1. Acharya T, Daar AS, Thorsteinsdóttir H, Martin DK, Smith AC, Nast S, Singer PA. Top 10 Biotechnologies for Improving Health in Developing Countries. Report: Program in Applied Ethics and Biotechnology- Canadian Program on Genomics and Global Health. University of Toronto Joint Centre for Bioethics. Foreword by Joshua Lederberg. 2002. 2. Acharya T, Daar AS, Dowdeswell E, Singer PA, Thorsteinsdóttir H. Genomics and Global Health. A Report of the Genomics Working Group of the Science and Technology Innovation Task Force of the United Nations Millennium Development Project Science and Technology Innovation Task Force, October 2004. In: UN Millennium Project Task Force on Science, Technology and Innovation – Genomics and Nanotechnology Working Group (Juma C, Yee- Cheong L, eds.). Innovation: Applying Knowledge in Development. Achieving the Millennium Development Goals. London: Earthscan, 2005. ISBN 1-84407-218-5 18
    • Curriculum Vitae, Daar AS 3. Caulfield T, Daar AS, Hamet P, Kroeger A, Ling V, McPherson A, Morrow J, Slater B, Closson T. A Report of the Expert Working Party on Human Genetic Materials, Intellectual Property and the Health Sector presented to Canadian Biotechnology Advisory Committee (CBAC). Human Genetic Materials: Making Canada’s Intellectual Property Regime Work for the Health of Canadians. October 2005. 4. Juma C (Co-Chair), Serageldin I (Co-Chair), Daar AS, member of Panel. “Freedom to Innovate: Biotechnology in Africa’s Development. Report of the High-Level African Panel on Modern Biotechnology. African Union. January 2007 Weblink: http://www.nepadst.org/doclibrary/pdfs/biotech_africarep_2007.pdf 5. Gold, Edward Richard, Adams, Wendy A., Bernier, Louise , Bubela, Tania, Cassivi, Luc, Castle, David, Cleret de Langavant, Ghislaine, Martin Cloutier, L., Daar, Abdallah S., Delerue, Hélène , Glass, Amy Jocelyn, Henry, Elisa, Knowles, Lori, Morin, Jean-Frédéric, Piper, Tina and Smith, Pamela J.D.,Toward a New Era of Intellectual Property: From Confrontation to Negotiation - A Report by the International Expert Group on Biotechnology, Innovation and Intellectual Property(September 9, 2008). Available at SSRN: http://ssrn.com/abstract=1260099 Journal Publications (Peer Reviewed) 1. Morris PJ, Ting A, Daar AS, Oliver D. B-cell alloantibodies and renal allografts. [Research Communication.] Lancet 1976 Aug 7;2(7980):312-3. 2. Daar AS, Morris PJ, Oliver DO. Leucocytosis is not a manifestation of rejection. British Medical Journal 1977 Dec 17;2(6102):1570-1. 3. Gray D, Shepherd H, Daar A, Oliver DO, Morris PJ. Oral versus intravenous high-dose steroid treatment of renal allograft rejection: The big shot or not? Lancet 1978 Jan 21;1(8056):117-8. 4. Daar AS, Finch RA. Graft avulsion: An unreported complication of axillofemoral bypass grafts. British Journal of Surgery 1978 Jun;65(6):442. 5. Daar AS. Neurilemoma of femoral nerve-a possible pitfall. British Journal of Clinical Practice 1981 Jun;35(6):240-1. 6. Daar AS, Merrill CR, Moolla SM, Clarke TN. Rectal examination and acid phosphatase: Evidence for persistence of a myth. British Medical Journal (Clin Res Ed) 1981 Apr 25;282(6273):1378-9. See also Daar AS. Rectal examination and acid phosphatase. British Medical Journal (Clincial Res Ed) 1981 Jun 20:282(6281):2055. 7. Daar AS, Fabre JW. Organ-specific IgM autoantibodies to liver, heart and brain in man: Generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis. Clinical Experimental Immunology 1981 Jul;45(1):37-47. 8. Daar AS, Ormiston MC. Scrotal Cancer - A notifiable occupational disease. British Journal of Clinical Practice 1981 Jul-Aug;35(7-8):281-2. 19
    • Curriculum Vitae, Daar AS 9. Daar AS, Fabre JW. Demonstration with monoclonal antibodies of an unusual mononuclear cell infiltrate and loss of normal epithelial membrane antigens in human breast carcinomas. Lancet 1981 Aug 29;2(8244):434-8. Patey Prize Article 10. Daar AS. Acute primary epiploic appendagitis. British Journal of Clinical Practice 1981 Sep;35(9):333-5. 11. Daar AS, Fuggle SV, Ting A, Fabre JW. Anomolous expression of HLA-DR antigens on human colorectal cancer cells. Journal of Immunology 1982 Aug;129(2):447-9. 12. Daar AS, Fuggle SV, Hart DNJ, Dalchau R, Abdulaziz Z, Fabre JW, Ting A, Morris PJ. Demonstration and phenotypic characterisation of HLA-DR positive interstitial dendritic cells widely distributed in human connective tissue. Transplantation Proceedings 1983;15:311-5. 13. Daar AS, Fabre JW. The membrane antigens of human colorectal cancer cells: Demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous express of HLA-DR. European Journal of Cancer and Clinical Oncology 1983 Feb;19(2):209-20. 14. Fuggle SV, Errasti P, Daar AS, Fabre JW, Ting A, Morris PJ. Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys: Differences in HLA- DR staining of tubules among kidneys. Transplantation 1983 Apr;35(4):385-90. 15. Daar AS. Doctor's beliefs and biochemical reality regarding acid phosphatase and rectal examination. Bristol Medico-Chirurgical Journal 1983;24. 16. Meyer D, Daar AS, Casey T, Fabre TW. Localisation of HLA-ABC and HLA-DR antigens in the human cornea: Practical significance for grafting technique and HLA typing. Transplantation Proceedings 1983;15:126. 17. Frostick SP, Collin J, Daar AS, Kettlewell M, Nolan DJ. Non-traumatic intramural haematoma: An unusual cause of duodenal obstruction. British Journal of Surgery 1984 Apr;71(4):313-4. 18. Galbraith KA, Daar AS, Gatter KC, Dunnill MS. Alveolar soft part sarcoma: Ultrastructual and immunohistological studies with monoclonal antibodies. British Journal of Clinical Practice 1984 Apr;38(4):154-6. 19. Rouse T, Daar AS, Collin J. Herniation through an iatrogenic ilial bone defect. British Journal of Clinical Practice 1984 Jun;38(6):231-2. 20. Rouse T, Collin J, Daar A. Isolated injury to the intestine from blunt abdominal injury. Injury 1984 Sep;16(2):131-3. 21. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984 Sep;38(3):287-92. 22. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation 1984 Sep;38(3):293-8. 23. Salahudeen S, Pingle A, Kazi M, Daar AS. Fistulisation of arterio-venous (AV) shunt vasculature in patients on haemodialysis. Emirates Medical Journal 1986;4:121-5. 20
    • Curriculum Vitae, Daar AS 24. Alfahim A, Daar AS. The first 100 thyroidectomies at Mafraq Hospital: A surgical profile. Emirates Medical Journal 1986;4:205-10. 25. Masri M, Naiem M, Daar AS. Age and dose dependence of cyclosporine G nephrotoxicity in BALB/c mice. Transplantation Proceedings 1987 Feb;19(1-Pt.2):1212-3. 26. Daar AS, Pingle S, Naiem M, Masri MA. Histologic changes in atrophic spleens of mice treated with cyclosporine A. Transplantation Proceedings 1987 Oct;19(5):4329-30. 27. Kazim S, Daar AS. Review of lymph node biopsies at a referral hospital in the UAE. Emirates Medical Journal 1987;5:222-5. 28. Masri MA, Naiem M, Pingle S, Daar AS. Cyclosporine A versus cyclosporine G: A comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice. Transplant International 1988 Apr;1(1):13-8. 29. Dalchau R, Daar AS, Fabre JW. The human Thy-1 molecule. Immunological Series 1989;45:185-96. 30. Masri MA, Naiem M, Daar AS. Immunopathological changes in the spleen of BALB/c mice treated with either cyclosporine A or cyclosporine G. Transplantation Proceedings 1989 Feb;21(1-Pt.1):952-3. 31. Daar AS. Ethical issues -- a Middle East perspective. Transplantation Proceedings 1989 Feb;21(1-Pt.2):1402-4. 32. Flanagan BF, Dalchau R, Allen AK, Daar AS, Fabre JW. Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunology 1989 Jun;67(2):67-75. 33. Daar AS, Sells RA. Living non related donor renal transplantation -- A reappraisal. Transplantation Review 1990;4:128-40. 34. Daar AS, Salahudeen AK, Pingle A, Woods HF. Ethics and commerce in live donor renal transplantation: Classification of the issues. Transplantation Proceedings 1990 Jun;22(3):922-4. 35. Salahudeen AK, Woods HF, Pingle A, Nur-El-Huda Suleyman M, Shakuntala K, Nandakumar M, Yahya TM, Daar AS. High mortality among recipients of bought living-unrelated donor kidneys. Lancet 1990 Sep 22;336(8717):725-8. 36. Gyasi HK, Zarroug AW, Matthew M, Joshi R, Daar A. Anaesthesia for renal transplantation in sickle cell disease. Canadian Journal of Anaesthesia 1990 Oct;37(7):778-85. 37. Daar AS. Renal transplantation in Islam: The basis for recent legal opinions. Emirates Medical Journal 1990;8:1-3. 38. Daar AS. The case for using living non-related donors to alleviate the world wide shortage of cadaver kidneys for transplantation. Annals of the Academy of Medicine, Singapore 1991 Jul;20(4):443-52. 39. Daar AS. Organ donation -- world experience; The Middle East. Transplantation Proceedings 1991 Oct;23(5):2505-7. 21
    • Curriculum Vitae, Daar AS 40. Reacher MH, Munoz B, Alghassany A, Daar AS, Elbualy M, Taylor HR. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Archives of Ophthalmology 1992 May;110(5):667-74. 41. Daar AS, Lim S, Thompson JF. First International Congress on Transplantation in Developing Countries. Transplantation Proceedings 1992;24:1645-2134. (Guest Editor) 42. al-Dhahry SH, Aghanashinikar PN, al-Hasani MK, Buhl MR, Daar AS. Antibodies to hepatitis C virus in Omani patients with renal disease. Transplantation Proceedings 1992 Oct;24(5):1938-9. 43. Naiem M, Amiry N, Hag A, Akhter S, Daar AS. Suppression of in vitro lymphocyte reactivity to PHA by lysates from human placentae: Lack of correlation with gravida number. Transplantation Proceedings 1992 Oct;24(5):1654-5. 44. Naiem M, Amiry N, Akhter S, Daar AS. Identification and characterisation of two glycoproteins of molecular weights 60 and 180 kd from human multigravid placenta having strong in vitro immunosuppressive activity. Transplantation Proceedings 1992 Oct; 24(5):1657-8. 45. Pingle A, Shakuntala RV, Zahir MB, Shanawaz M, Masri MA, Hayes K, Daar AS, Dhawan IK. Factors responsible for elimination of potential kidney donors in a living-related donor kidney transplant program. Transplantation Proceedings 1992 Oct;24(5):1889-90. 46. Aghanashinikar PN, al-Dhahry SH, al-Marhuby HA, Buhl MR, Daar AS, Al-Hasani MK. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases. Transplantation Proceedings 1992 Oct;24(5):1913-4. 47. Pingle A, Shakuntala RV, Shanawaz M, Zaheer MB, Yassin I, Masri M, Daar AS, Dhawan IK. Impact of renal transplantation on liver disease of diverse etiology. Transplantation Proceedings 1992 Oct;24(5):1916. 48. Daar AS. Nonrelated donors and commercialism: A historical perspective. Transplantation Proceedings 1992 Oct;24(5):2087-90. 49. Daar AS. Rewarded gifting. Transplantation Proceedings 1992 Oct;24(5):2207-11. 50. Kabir S, Aebersold R, Daar AS. Identification of a novel 4 kDa immunoglobulin-A-binding peptide obtained by the limited proteolysis of jacalin. Biochimica et Biophysica Acta 1993 Feb 13;1161(2-3):194-200. 51. Al Dhahry SH, Aghanashinikar PN, al-Hasani MK, Buhl MR, Daar AS. Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease. Infection 1993 May- Jun;21(3):164-7. 52. Daar AS. Commerce in transplantable human kidneys. Revista Espanola de Trasplantes 1993;2:58-61. 53. Aghanashinikar PN, Daar AS, Marhuby H, Woods HF, Nandakumar M, Yaqoob M, White AG, Albusaidi QM, al Hassani MK. Omani experience with a heterogeneous group of kidney transplant recipients over a 10-year period. Transplantation Proceedings 1993 Jun;25(3):2359-60. 22
    • Curriculum Vitae, Daar AS 54. Al Dhahry SHS, Al Marhuby HA, Prabakar N, Buhl MR, Daar AS, Al Hassani MK. Prevalence of hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal disease: A seroprevalence study. Annals of Saudi Medicine 1994;14:312-5. 55. Daar AS. Living-organ donation: Time for a donor charter. Clinical Transplantation 1994:376-80. 56. Daar AS. Xenotransplantation and religion: The major monotheistic religions. Xeno 1994;2:61-4. 57. Daar AS. Rampant commercialism and "rewarded gifting": Defining the acceptable. Nefrologia 1994;14:74-7. 58. Daar AS. The body, the soul and organ donation: beliefs of the major world religions. Nefrologia 1994;14:78-81. 59. Kabir S, Daar AS. The composition and properties of jacalin, a lectin of diverse applications obtained from the jackfruit (Artocarpus heterophyllus) seeds. Immunological Investigations 1994 Apr;23(3):167-88. 60. Venkataram MN, White AG, Leeny WA, al Suwaid AR, Daar AS. HLA antigens in Omani patients with vitiligo. Clinical and Experimental Dermatology 1995 Jan;20(1):35-7. 61. Daar AS, Mohsin N, Chandy M, Marhubi H. Current status of organ transplantation in the Sultanate of Oman. Bulletin of the Asian Society of Transplantation 1995;3:2021. 62. Ahmed ISA, Al Gharibi KN, Daar AS, Kabir S. The composition and properties of date proteins. Food Chemistry 1995;53:441-6. 63. Kabir S, Daar AS. Maturation of immunoglobulin-A binding proteins in the seeds of jackfruit. Biochemistry and Molecular Biology International 1995 Apr;35(5):1049-57. 64. Kabir S, Ahmed IS, Daar AS. The binding of jacalin with rabbit immunoglobulin G. Immunological Investigations 1995;24(5):725-35. 65. Kabir S, Grant C, Daar AS. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. Cancer Letters 1995;95:207-12. 66. Al Hassani MK, Sharma U, Mohsin N, Aghanashinikar P, al Maiman Y, Kumar MN, Daar AS. Pregnancy in renal transplantation recipients: Outcome and complications in 44 pregnancies. Transplantation Proceedings 1995 Oct;27(5):2585. 67. Daar AS. Developments in immunosuppressive therapy. Transplantation Proceedings 1995 Oct;27(5):2571-5. 68. White AG, Al Riyami HA, Kuchipudi P, Daar AS. Immunoglobulins, Immunoglobulin G subclasses and complement in adult Omanis. Annals of Saudi Medicine 1996. 69. Pradeep JK, Kehinde EO, Daar AS. Symptomatic response to ascorbic acid. British Journal of Urology 1996 Feb;77(2):319-20. 23
    • Curriculum Vitae, Daar AS 70. Grant C, Daar AS. Preventing medical negligence in the Gulf region. World Health Forum 1996;17(3):1-4. 71. Marshall PA, Thomasma DC, Daar AS. Marketing human organs: The autonomy paradox. Theoretical Medicine 1996 Mar;17(1):1-18. 72. Shaheen FAM, Albar M, Daar A. Cadaveric organ transplantation in developing countries: Socio-economic, religious and ethical issues. Pakistani Medical Journal 1996. 73. Agarwal AK, White AG, Ali M, Leheny WA, Daar AS. HLA antigens in an Omani population with dilated cardiomyopathy. International Journal of Cardiology 1996 Jul 5;55(1):29-32. 74. Daar AS. An emerging transplant force -- Developing countries: Middle East and the Indian subcontinent. Transplantation Proceedings 1997 Feb-Mar;29(1-2):1577-9. 75. White AG, Bogh J, Leheny W, Kuchipudi P, Varghese M, al Riyami H, al Hashmi S, Daar AS. HLA antigens in Omanis with blinding trachoma: Markers for disease susceptibility and resistance. British Journal of Ophthalmology 1997 Jun;81(6):431-4. 76. Rothman DJ, Rose E, Awaya T, Cohen B, Daar A, Dzemeshkevich SL, Lee CJ, Munro R, Reyes H, Rothman SM, Schoen KF, Scheper-Hughes N, Shapira Z, Smit H. The Bellagio Task Force Report on Transplantation, Bodily Integrity, and the International Traffic in Organs. Transplantation Proceedings 1997 Sep;29(6):2739-45. 77. Hoffenberg R, Lock M, Tilney N, Casabona C, Daar AS, Guttmann RD, Kennedy I, Nundy S, Radcliffe-Richards J, Sells RA [International Forum for Transplant Ethics]. Should organs from patients in permanent vegetative state be used for transplantation? Lancet 1997 Nov;350:1320-1. 78. Harris PF, Abu-Hijleh MF, Grant CS, Daar AS. Brachial plexus palsy and spinal subarachnoid pneumatosis following trauma. Clinical Anatomy 1997;10(6):419-23. 79. Daar AS. Ethics of xenotransplantation: Animal issues, consent, and likely transformation of transplant ethics. World Journal of Surgery 1997 Nov-Dec;21(9):975-82. 80. Bhargava D, Bhusnurmath S, Daar AS. Chondroid syringoma of the nose: report of a case. Journal of Laryngology and Otology 1997 Sep;111(9):862-4. 81. Daar AS. The response to the challenge of organ shortage in the Middle East region: A summary. Transplantation Proceedings 1997 Dec;29(8):3215-6. 82. Daar AS. The New Indian Law for Organ Transplantation: One More Step Against Traffic of Organs. Bulletin of the Catalan Transplantation Society 1997;1(1):16. 83. Daar AS, Kolbe RJ. Ethics, Equity and the Health-for-All Strategy: The Missing Dimensions. World Health Forum 1997;18(2). 84. Daar AS, Land W, Yahya TM, Schneewind K, Gutmann T, Jakobsen A. Living donor renal transplantation: Evidence-based justification for an ethical option. Transplant Reviews 1997;11:95-109. 85. Daar AS. Brain death, organ donation and commerce in organs -- features of the new Indian law. Bulletin of the Catalan Transplantation Society 1997. 24
    • Curriculum Vitae, Daar AS 86. Daar AS, Shaheen FAM, Al Bar M, Al Khadher A. Transplantation in Developing Countries -- Issues Bearing Upon Ethics. Pakistani Journal of Medical Ethics 1997;2(4):4-7. 87. Kennedy I, Sells RA, Daar AS, Guttmann RD, Hoffenberg R, Lock M, Radcliffe-Richards J, Tilney N [International Forum for Transplant Ethics]. The case for "presumed consent" in organ donation. Lancet 1998 May 30;351:1650-2. 88. Daar AS, Marshall P. Culture and psychology in organ transplantation. World Health Forum 1998;19(2):124-32. 89. Radcliffe-Richards J, Daar AS, Guttmann RD, Hoffenberg R, Kennedy I, Lock M, Sells RA, Tilney N [International Forum for Transplant Ethics]. The case for allowing kidney sales. Lancet 1998 Jun 27;351:1950-2. 90. Daar AS. Quest for organ donors: development of transplant ethics. Transplantation Proceedings 1998 Nov;30(7):3616. 91. Daar AS. Prospects of organ sharing and strategies for increasing transplants in Asia. Transplantation Proceedings 1998 Nov;30(7):3649. 92. Daar AS. An overview of transplantation issues in the Middle East. Transplantation Proceedings 1998 Nov;30(7):3638. 93. Marshall PA, Daar AS. Cultural and psychological dimensions of human organ transplantation. Annals of Transplantation 1998;3(2):7-11. 94. Daar AS. Societal Issues in Organ Transplantation. Annals of Transplantation 1998;3(2):5-6. 95. Daar AS. Paid organ donation: The Grey Basket concept. Journal of Medical Ethics 1998 Dec;24(6):365-8. 96. Daar AS. Analysis of factors for the prediction of the response to xenotransplantation. Annals of the New York Academy of Sciences 1998 Dec 30;862:222-33. 97. White AG, Leheny W, Kuchipudi P, Varghese M, Al Riyami H, Al Hashmi S, Daar AS. Histocompatibility antigens in Omanis: Comparison with other Gulf populations and implications for disease association. Annals of Saudi Medicine 1999;19:193-6. 98. Daar AS. The evolution of organ transplantation in the Middle East. Transplantation Proceedings 1999 Feb-Mar;31(1-2):1070-1. 99. Mohsin N, Daar AS. Immunosuppressive drugs in renal transplantation. Kidney Forum 1999;1(2):13-7. 100.Daar AS. Animal-to-human organ transplants -- a solution or a new problem? Bulletin of the World Health Organization 1999;77(1):54-61. 101.Daar AS. Living non-related kidney transplantation: Time to be taken seriously. Transplantation Proceedings 1999 Jun;31(4):1769-71. 25
    • Curriculum Vitae, Daar AS 102.Daar AS. Xenotransplantation: Informed consent/contract and patient surveillance. Biomedical Ethics 1999;4(3):87-91. 103.Grant CS, Al-Kindy N, Machado N, Daar AS. Laparoscopic Surgery at Sultan Qaboos University Hospital. SQU Journal of Scientific Research - Medical Sciences 2000;1:115-19. 104.Scrimgeour EM, Daar AS. Schistosomiasis: Clinical relevance to surgeons in Australasia and diagnostic update. Australian and New Zealand Journal of Surgery 2000 Mar;70(3):157-61. 105.Daar AS. Xenotransplantation und die mittelostlichen Religionen. Nieren und Hochdruckkrankheiten (Official Journal of the Gesellschaft fur Nephrologie). 2000 Mar;29:119-27. 106.Daar AS. Cultural and societal issues in organ transplantation: Examples from different cultures. Transplantation Proceedings 2000 Nov;32(7):1480-1. 107.Daar AS. Xenotransplantation and cloning: Working with the World Health Organization to develop ethical guiding principles. Transplantation Proceedings 2000 Nov;32(7):1549-50. 108.Ethics Committee, Human Genome Organization. (Knoppers BM, Chadwick R, Takebe H, Kirby M, Berg K, RenZong Q, Macer D, Cantu J-M, Wertz DC, Murray TH, Daar AS, Verma I, Engels EM) Genetic Benefit Sharing. Science 2000;290:49. 109.Daar AS. Altruism and reciprocity in organ donation: Compatible or not? Transplantation 2000;70:704-5. 110.Williams F, Curran MD, Leheny WA, Daar AS, Middleton D. Characterization of HLA-B*3921 and confirmation of HLA-B*4415, two variant HLA-B alleles identified in the Omani population. Tissue Antigens 2000 Oct;56(4):376-9. 111.Middleton D, Williams F, Meenagh A, Daar AS, Gorodezky C, Hammond M, Nascimento E, Briceno I, Perez MP. Analysis of the distribution of HLA-A alleles in populations from five continents. Human Immunology 2000 Oct;61(10):1048-52. 112.Singer PA, Daar AS. Avoiding frankendrugs. Nature Biotechnology 2000 Dec;18(12):1225. 113.Knoppers BM, Chadwick R, Takebe H, Berg K, Cantu J-M, Daar AS, Engels EM, Kirby M, Macer D, Murray TH, Ren-Zong Q, Verma IC, Wertz DC [Ethics Committee of the Human Genome Organization]. HUGO Urges Genetic Benefit-Sharing. Community Genetics 2000;3:88-92. 114.Hugo Ethics Committee statement on benefit sharing - April 9, 2000. Knoppers BM, Chadwick R, Takebe H, Berg K, Cantu JM, Daar AS, Engels EM, Kirby M, Macer D, Murray TH, Qui RZ, Wertz DC, Verma IC. (HUGO Ethics Committee). Clinical Genetics 2000 Nov;58 (5):364-6. 115.Middleton D, Williams F, Meenagh A, Daar AS, Gorodezky C, Hammond M, Nascimento E, Briceno I, Perez MP. Analysis of the distribution of HLA-A alleles in populations from five continents. Human Immunology 2000;61:1048-52. 26
    • Curriculum Vitae, Daar AS 116.Daar AS, al Khitamy AB. Bioethics for Clinicians: 21. Islamic Bioethics. Canadian Medical Association Journal 2001;164(1):60-3. 117.Daar AS. Southern Mediterranean, Middle East, and Subcontinent organ transplantation activity. Transplantation Proceedings 2001;33(2-1):1993-4. 118.Tilney NL, Guttmann RD, Daar AS, Hoffenberg R, Kennedy I, Lock M, Radcliffe-Richards J, Sells RA, for the International Forum on Transplant Ethics. The New Chimaera: The industrialization of organ transplantation. Transplantation 2001;71:591-3. 119.Daar AS. Choosing Risk-Benefit Analysis or Precautionary Principle as Our Approach to Clinical Xenotransplantation. Graft 2001;4(2):164-6. 120.Williams F, Meenagh A, Darke C, Acosta A, Daar AS, Gorodezky C, Hammond M, Nascimento E, Middleton D. Analysis of the distribution of HLA-B alleles in populations from five continents. Human Immunology 2001;62(6):645-50. 121.Daar AS, Al Khitamy AB. Islamic Bioethics. Pakistan Journal of Medical Ethics 2001; 4(1): 14-8; reprinted from Canadian Medical Association Journal 2001;164:60-3. 122.Singer PA, Daar AS. Harnessing Genomics and Biotechnology to Improve Global Health Equity. Science 2001 Oct;294(5540):87-9. 123.Scrimgeour EM, Ahmed A, Sallam J, Khoul R, Al-Dhahry SHS, Daar AS, El-Khatim HS, Idris MA, Date A. Schistosomiasis in patients in the Sultanate of Oman. Annals of Saudi Medicine 2001;21(3-4):170-3. 124.Dowdeswell E, Daar AS, Singer PA. Getting governance into genomics. Science and Public Policy 2005; 32(6): 497-498 125.Al Alam F, Kehinde EO, Daar AS, Albar MA. The management of a true hermaphrodite in an Islamic country. British Journal of Sexual Medicine 2002;26(1):24-26. 126.Daar AS. Strangers, intimates, and altruism in organ donation. Transplantation 2002 Aug;74(3):424-6. 127.Gold ER, Castle D, Cloutier LM, Daar AS, Smith PJ. Needed: Models of Biotechnology Intellectual Property. Trends in Biotechnology 2002 Aug;20(8):327-9. 128.Daar AS, Thorsteinsdóttir H, Martin DK, Smith AC, Nast S, Singer PA. Top 10 Biotechnologies for Improving Health in Developing Countries. Nature Genetics 2002 Oct;32(2):229-32. 129.Daar AS, Sheremeta L. The Science of Stem Cells: Some Implications for Law and Policy. Health Law Review 2002 Winter;11(1):5-13 130.Dowdeswell E, Daar AS, Singer PA. Bridging the Genomics Divide. Global Governance Journal 2003;9:1-6. 131.Caulfield T, Upshur REG, Daar AS. DNA databanks and consent: A suggested policy option involving an authorization model. BioMedCentral Medical Ethics 2003 Jan;4:E1. Available online at http://www.biomedcentral.com/1472-6939/4/1. 27
    • Curriculum Vitae, Daar AS 132.Benatar SR, Daar AS, Singer PA. Global Health Ethics: The rationale for mutual caring. International Affairs 2003;79:107-38. 133.Knox-Macaulay H, Ayyaril M, Nusrat N, Daar AS. Colonic pseudo-obstruction in sickle cell disease. Southern Medical Journal 2003 Jan;96(1):93-5. 134.Mnyusiwalla A, Daar AS, Singer PA. “Mind the Gap”: Science and Ethics in Nanotechnology. Nanotechnology 2003;14:R9-13. 135.Thorsteinsdóttir H, Daar AS, Smith RD, Singer PA. Genomics – A Global Public Good? Lancet 2003;361(9361):891-2. 136.Daar AS. Paid Organ Donation and Organ Commerce: Continuing the Ethical Discourse. Transplantation Proceedings 2003 May;35(3):1207-9. 137.Choudhry S, Daar AS, Radcliffe-Richards J, Guttmann RD, Hoffenberg R, Lock M, Sells RA, Tilney N. Unrelated living organ donation: ULTRA needs to go. Journal of Medical Ethics 2003 Jun;29(3):169-70. 138.Wright L, Daar AS. Ethical Aspects of Living Donor Kidney Transplantation and Recipient Adherence to Treatment. Progress in Transplantation 2003 Jun;13(2):105-9. 139.McKneally MF, Daar AS. Introducing New Technologies: Protecting Subjects of Surgical Innovation and Research. World Journal of Surgery 2003 Aug;27(8):930-4; discussion 934-5. Epub 2003 Jun 26. 140.Daar AS, Dowdeswell E, Singer PA. Genome Diplomacy: Canada’s Crucial Role. Policy Options 2003;24(8):56-61. 141.Caulfield T, Sheremeta L, Daar AS. Somatic cell nuclear transfer – how science outpaces the law. Nature Biotechnology 2003 Sep;21(9):969-70. 142.Mohsin N, Marhuby H, Maimani Y, Aghanishankar P, Al-Hassani M, Daar AS. Development of morbid obesity after transplantation in Laurence Moon Biedle syndrome. Transplantation Proceedings 2003 Nov;35(7):2619. 143.Mohsin N, Marhuby H, Maimani Y, Aghanishankar P, Al-Hassani M, Daar AS. Living kidney donation for the mentally impaired: A case report. Transplantation Proceedings 2003 Nov;35(7):2571-2. 144.Daar AS. Xenotransplantation – Recent Scientific Developments and Continuing Ethical Discourse. Transplantation Proceedings 2003 Nov;35(7):2821-2. 145.Varmus H, Klausner R, Zerhouni E, Acharya T, Daar AS, Singer PA. Public Health. Grand Challenges in Global Health. Science 2003 Oct 17;302(5644):398-9. 146.Singer PA, Benatar SR, Bernstein M, Daar AS, Dickens BM, MacRae S, Upshur REG, Wright L, Zlotnik Shaul R. Ethics and SARS: Learning Lessons from Toronto. British Medical Journal 2003;327:1342-4. 147.Daar AS, Sheremeta L. The Science of Stem Cells: Ethical, Legal and Social Issues. Experimental and Clinical Transplantation 2003 Dec;1(2):139-46. 28
    • Curriculum Vitae, Daar AS 148.Acharya T, Daar AS, Singer PA. Biotechnology and the UN’s Millennium Development Goals. Nature Biotechnology 2003 Dec;21(12):1434-6. 149.Smith RD, Thorsteinsdottir H, Daar AS, Gold ER, Singer PA. Genomics knowledge and equity: a global public goods perspective of the patent system. Bulletin Of The World Health Organization 2004 May;82(5):385-9. 150.Acharya T, Kumar NK, Singer PA, Daar AS, Muthuswamy V. Harnessing genomics to improve health in India – an executive course to support genomics policy. BioMedCentral Health Research and Policy Systems 2004 May 19;2(1):1. 151.Gold RE, Adams W, Castle D, Cleret de Langavant G, Cloutier LM, Daar AS, Glass A, Smith PJ, Bernier L. The Unexamined Assumptions of Intellectual Property: Adopting an Evaluative Approach to Patenting Biotechnological Innovation. Public Affairs Quarterly 2004 Oct;18(4):299-344. 152.Daar AS, Bhatt A, Court E, Singer PA. Stem Cell Research and Transplantation: Science Leading Ethics. Transplantation Proceedings, 2004 Oct;36(8):2504-6. 153.Daar AS. Non-heart-beating Donation: ten evidence-based ethical recommendations. Transplantation Proceedings 2004;36(7):1885-7. 154.Daar AS. Paid organ procurement: Pragmatic and Ethical Viewpoints. Transplantation Proceedings 2004;36(7):1876-7. 155.Acharya T, Kennedy R, Daar AS, Singer PA. Biotechnology to Improve Health in Developing Countries. Memórias do Instituto Oswaldo Cruz 2004 Jun;99(4):341-50. 156.Court E, Daar AS, Martin E, Acharya T, Singer PA. Will Prince Charles et al diminish the opportunities of developing countries in nanotechnology? Nanotech Web 2004 Jan 28 http:// nanotechweb.org/articles/society/3/1/1/1. 157.Daar AS, Sahni P, Singer PA. Genomics and Global Health: the work of the University of Toronto Joint Centre for Bioethics. Acta Bioethica 2004;10(2):213-25. 158.Sheremeta L, Daar AS. The case for publicly funded research on ethical, environmental, economic, legal and social issues raised by nanoscience and nanotechnology (NE3LS). Health Law Review 2004;12(3):74-7. 159.Thorsteinsdottir H, Quach U, Martin DK, Daar AS, Singer PA. Introduction: promoting global health through biotechnology. Nature Biotechnol 2004 Dec;22Suppl:DC3-7. 160.Ferrer M, Thorsteinsdottir H, Quach U, Singer PA, Daar AS. The scientific muscle of Brazil's health biotechnology. Nature Biotechnol 2004 Dec;22 Suppl:DC8-12. 161.Thorsteinsdottir H, Saenz TW, Quach U, Daar AS, Singer PA. Cuba--innovation through synergy. Nature Biotechnol 2004 Dec;22 Suppl:DC19-24. 162.Motari M, Quach U, Thorsteinsdottir H, Martin DK, Daar AS, Singer PA. South Africa-- blazing a trail for African biotechnology. Nature Biotechnol 2004 Dec;22 Suppl:DC37-41. 29
    • Curriculum Vitae, Daar AS 163.Abdelgafar B, Thorsteinsdottir H, Quach U, Singer PA, Daar AS. The emergence of Egyptian biotechnology from generics. Nature Biotechnol 2004 Dec;22 Suppl:DC25-30. 164.Kumar NK, Quach U, Thorsteinsdottir H, Somsekhar H, Daar AS, Singer PA. Indian biotechnology--rapidly evolving and industry led. Nature Biotechnol 2004 Dec;22 Suppl:DC31-6. 165.Zhenzhen L, Jiuchun Z, Ke W, Thorsteinsdottir H, Quach U, Singer PA, Daar AS. Health biotechnology in China--reawakening of a giant. Nature Biotechnol 2004 Dec;22 Suppl:DC13-8. 166.Wong J, Quach U, Thorsteinsdottir H, Singer PA, Daar AS. South Korean biotechnology--a rising industrial and scientific powerhouse. Nature Biotechnol 2004 Dec;22 Suppl:DC42-7. 167.Thorsteinsdottir H, Quach U, Daar AS, Singer PA. Conclusions: promoting biotechnology innovation in developing countries. Nature Biotechnol 2004 Dec;22 Suppl:DC48-52. 168.Merali Z, Boulyjenkov V, Singer PA, Daar AS. The ELSI Genetics Regulatory Resource Kit: A Tool for Policymakers in Developing Countries. Journal of Law, Medicine and Ethics 2004 Winter;32(4):692-700. 169.Isasi RM, Knoppers BM, Singer PA, Daar AS. Legal and Ethical Approaches to Stem Cell and Cloning Research: A Comparative Analysis of Policies in Latin America, Asia, and Africa. Journal of Law, Medicine and Ethics 2004 Winter;32(4):626-40. 170.Acharya T, Daar AS, Thorsteinsdottir H, Dowdeswell E, Singer PA. Strengthening the Role of Genomics in Global Health. PLoS Med. 2004 Dec;1(3):e40. Also reprinted in Rotman Magazine 2005 Winter. 171.Mohsin N, Budrudine M, Pakkyara A, Amitabh J, Daar AS. High Incidence of Early Post Transplant Diabetes Mellitus (PTDM) in an Omani Population. Transplant. Proc. 2005 Sep;37(7):2911-2. 172.Mohsin N, Pakkyara A, Budrudine M, Obaid F, Amitabh J, Daar AS. Low Tacrolimus Dose Requirements in Renal Transplant Recipients in the Omani Population: Implications for Pharmacogenetics? Transplant. Proc. 2005 Sep;37(7):3093-4. 173.Acharya T, Abdur Rab M, Singer PA, Daar AS. Harnessing genomics to improve health in the Eastern Mediterranean Region - an executive course in genomics policy. Health Res Policy Syst. 2005 Jan 21;3(1):1. 174.Smith AC, Mugabe J, Singer PA, Daar AS. “Harnessing genomics to improve health in Africa” - an executive course to support genomics policy. Health Res Policy Syst. 2005 Jan 24;3(1):2. 175.Bernstein M, Bampoe J, Daar AS. Ethical issues in molecular medicine of relevance to surgeons. Can J Surg. 2004 Dec;47(6):414-21. Review. Erratum in: Can J Surg. 2005 Feb;48(1):48. 176.Daar AS, Singer PA. Pharmacogenetics and Geographical Ancestry: Implications for Drug Development and Global Health. Nature Reviews Genetics 2005 Mar;6(3):241-6. Also reprinted in Global Forum Update on Research for Health 2005;2:118-25. 30
    • Curriculum Vitae, Daar AS 177.Singer PA, Bhatt A, Frew S, Greenwood H, Persad DL, Salamanca-Buentello F, Seguin B, Taylor AD, Thorsteinsdottir H, Daar AS. The Critical Role of Genomics in Global Health. Global Forum Update on Research for Health 2005;2:113-7. 178.Daar AS. The world health organization resolution on human organ transplantation: will it result in action? Transplantation 2005 Mar 27;79(6):641-2. 179.Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men. Prostate Cancer Prostatic Dis. 2005 Mar;8(1):84-90. 180.Wright L, Ross K, Daar AS. The roles of a bioethicist on an organ transplantation service. Am J Transplant. 2005 Apr;5(4 Pt 1):821-6. 181.Salamanca-Buentello F, Persad DL, Court EB, Martin DK, Daar AS, Singer PA. Nanotechnology and the Developing World. PLoS Med. 2005 May;2(5):e97. Epub 2005 Apr 12. 182.Court EB, Daar AS, Persad DL, Salamanca-Buentello F, Singer PA. Tiny technologies for the global good. NanoToday 2005 May; Materials Today Suppl:14-5. 183.Singer PA, Salamanca-Buentello F, Daar AS. Harnessing Nanotechnology to Improve Global Equity. Issues in Science and Technology 2005; Summer:57-64. 184.Benatar SR, Daar AS, Singer PA. Global Health Challenges: The need for an expanded discourse on bioethics. PLoS Med 2005 Jul;2(7):e143. Epub 2005 Jul 26. 185.Kehinde EO, Mojiminiyi OA, Sheikh M, Al-Awadi KA, Daar AS, Al-Hunayan A, Anim JT, Al- Sumai AA. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men. British Journal of Urology (Internationa)l 2005 Aug;96(3):308-12. 186.Nisker J, Daar AS. Moral Presentation of Genetics-Based Narratives for Public Understanding of Genetic Science and its Implications. Public Understanding of Science 2005; 15(2006):113-23. 187.Thorsteinsdóttir H, Saenz TW, Singer PA, Daar AS. Different Rhythms of Health Biotechnology in Brazil and Cuba. Journal of Business Chemistry 2005 Sep;2(3):99-106. 188.Mohsin N, Budruddin M, Pakkyara A, Darweesh A, Nayyer M, Amitabh J, Daar AS. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus. Exp Clin Transplant 2005 Dec;3(2):366-9. 189.Nisker J, Martin DK, Bluhm R, Daar AS. Theatre as a Public Engagement Tool for Health- Policy Development. Health Policy (78) 2006. pp 258-271. doi. 10.1016/j.healthpol.2005.10.029 190.Persad DL, Quach U, Thorsteinsdóttir H, Salamanca-Buentello F, Singer PA, Daar AS. Enabling Knowledge Societies for Science and Technology in Developing Countries. International Journal of Biotechnology 2006;8(1/2):4-22. 31
    • Curriculum Vitae, Daar AS 191.Thorsteinsdóttir H, Daar AS, Singer PA, Archambault E, Aranachalam S. Health Biotechnology Publishing Takes-Off in Developing Countries. International Journal of Biotechnology 2006;8(1/2):23-42. 192.Quach U, Thorsteinsdóttir H, Renihan J, Bhatt A, Costa von Aesch Z, Singer PA, Daar AS. Biotechnology Patenting Takes Off in Developing Countries. International Journal of Biotechnology 2006;8(1/2):43-59. 193.Greenwood HL, Thorsteinsdóttir H, Perry G, Renihan J, Singer PA, Daar AS. Regenerative Medicine: New Opportunities for Developing Countries. International Journal of Biotechnology 2006;8(1/2):60-77. 194.Séguin B, State L, Singer PA, Daar AS. Scientific Diasporas as an Option for Brain Drain: Re-circulating Knowledge for Development. International Journal of Biotechnology 2006;8(1/2):78-90. 195.Frew SE, Sammut SM, Siu WW, Daar AS, Singer PA. The Role of the Domestic Private Sector in Developing Countries for Addressing Local Health Needs. International Journal of Biotechnology 2006;8(1/2):91-102. 196.Mackie J, Taylor AD, Daar AS, Singer PA. Corporate Social Responsibility Strategies Aimed at the Developing World: Perspectives from Bioscience Companies in the Industrialized World. International Journal of Biotechnology 2006;8(1/2):103-118. 197.Dowdeswell E, Daar AS, Singer PA. Increasing Human Security through Biotechnology. International Journal of Biotechnology 2006;8(1/2):119-131. 198.Dowdeswell E, Daar AS, Acharya T, Singer PA. Realizing the Promise of Genomics: Exploring Governance. International Journal of Biotechnology 2006;8(1/2):132-141. 199.Singer PA, Daar AS, Salamanca-Buentello F, Court E. Nano-Diplomacy. Georgetown Journal of International Affairs 2006; Winger/Spring:129-37. 200.Mackie JE, Taylor AD, Finegold DL, Daar AS, Singer PA. Lessons on Ethical Decision- Making from the Bioscience Industry. PLoS Medicine 2006 May;3(5):e129. 201.Daar AS, Greenwood HL. Beyond Transplantation: Regenerative Medicine and Its Potential Roles. Transplantation 2005. In press. 202.Dowdeswell E, Daar AS, Singer PA. Getting governance into genomics. Science and Public Policy 2005 Dec;32(6):1-2. 203.Kehinde EO, Akanji AO, Memon A, Bashir AA, Daar AS, Al-Awadi kA, Fatinikin T. Prostate Cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. Int. Urol Nephrol. 2006; 38(1): 33-44. 204.Seguin B, Singer PA, Daar AS. Scientific Diasporas. Science. 2006 Jun 16; 312(5780): 1602-3 205.Frew SE, Rezaie R, Sammut S, Ray M, Daar AS, Singer P. 2006. India’s Home-Grown Health Biotechnology Sector at a Crossroads. Nature Biotechnology. 2007; 25 (4): 403-417 32
    • Curriculum Vitae, Daar AS 206.Greenwood HL, Singer PA, Downey GP, Martin DK, Thorsteinsdottir H, Daar AS. Regenerative Medicine and the Developing World. PLoS Medicine. 2006;(3). (In Press} 207.Mahroum, S., Eldridge E. and Daar A. Transnational Diaspora Options: How Developing Countries Could Benefit from their Emigrant Populations. IJMS: International Journal on Multicultural Societies. 2006, vol.8, no.1, pp. 25-42. UNESCO. ISSN 1817-4574. www.unesco.org/shs/ijms/vol8/issue1/art2 208.Daar AS, Scherer SW and Hegele RA (2006) Large scale copy-number variation in the human genome: a time for questions. Nature Reviews Genetics (2006 June) 7: 414-414 doi:10.1038/nrg1884 209.Singh JA, Daar AS. The 20-year African biotech plan. Nature Biotechnol. 2008 Mar;26(3):272-4. 210.Daar AS. The case for a regulated system of living kidney sales. Nature Clinical Practical Nephrology. 2006 Nov;2(11): 600-1 211.Mohsin N, Nooyi C, Jha A, Budruddin M, Kamble P, Khalil M,, Pakkyarra A, Mohammed E, Ahmed H, Daar AS. Retinal injury as an early manifestation of post-transplant thrombotic microangiopathy: recovery with plasma exchanges and conversion to sirolimus- case report and review of literature. Transplant Proc. 2007 May; 39 (4): 1272-5. 212.Mohsin N, Budruddin M, Kamble P, Khalil M, Pakkyarra A, Jha A, Mohammed E, Ahmed H, Ahmed J, Thomas S, Campistol JM, Daar AS. Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporine to sirolimus. Transplant Proc. 2007 May; 39 (4): 1267-71. 213.Mohsin N, Budruddin M, Khalil M, Pakkyarra A, Jha A, Mohammed E, Kamble P, Ahmed H, Militsala E, Prabhakar NA, Al-Marhuby H, Ahmed J, Daar AS. Donor gender balance in a living-related kidney transplantation program in Oman. Transplant Proc. 2007 May;39(4):803-6. 214.Thorsteinsdottir H, Daar A, Singer PA. Innovation Cultures in Developing Countries: TheCase of Health Biotechnology. Comparative Technology Transfer and Society. (5) 2; August 2007; 178-201 215.Daar AS, Greenwood HL. A proposed definition of regenerative medicine. Journal of Tissue Engineering and Regenerative Medicine. May/June 2007. Vol 1 (3) pp 179-184 Online Issn. 1932-7005. Print Issn: 1932-6254. DOI: 10.1002/term.20. 216.Singer PA, Taylor AD, Daar AS, Upshur REG, Singh JA, Lavery, JV. Grand Challenges in Global Health: The Ethical, Social and Cultural Program. PLoS Medicine Vol 4, No. 9, e 265. doi:10.1371/journal.pmed.o040265. September 2007. 217.Berndtson K, Daid T, Tracy CS, Bhan A, Cohen ERM, Upshur REG, Singh JA, Daar AS, Lavery JV, Singer PA. Grand Challenges in Global Health: Ethical, Social, and Cultural Issues based on Key Informant Perspectives. PLoS Medicine Vol 4, No. 9, e 268. doi:10.1371/journal.pmed.o040265. September 2007. 33
    • Curriculum Vitae, Daar AS 218.Bhan AL, Singh JA, Upshur REG, Singer PA, Daar AS. Grand Challenges in Global Health: Engaging Civil Society Organization in Biomedical Research in Developing Countries. PLoS Medicine Vol. 4, No. 9, e272 doi:10.1371/journal.pmed.0040272. 219.Tindana PO, Singh JA, Tracy SC, Upshur REG, Daar AS, Singer PA, Frohlich, J, Lavery JV. Grand Challenges in Global Health: Community Engagement in Research in Developing Countries. PLoS Medicine Vol. 4, No. 9, e273 doi:10.1371/journal.pmed.0040273 220.Singer PA, Berndtson K, Tracy SC, Cohen ERM, Masum H, Daar AS, Lavery JV. A tough transition. Nature. September 2007. Vol 449, 160-163.. 221.Taylor AD, Brook D, Watters D, Dowdeswell E, Daar AS, Singer PA. North-South Partnerships – A study of Canadian Firms. Nature Biotechnology 25(9), 978-9. September 2007. 222.Daar AS, Singer PA, Persad D, Pramming S, Matthews D, Beaglehole R, Bernstein A, Borysiewicz L, Colagiuri S, Ganguly N, Glass R, Finewood D, Koplan J, Nabel E, Sarna G, Sarrafzadegan N, Smith R, Yach D, Bell J. Grand Challenges in Chronic Non-Communicable Diseases. Nature. November 2007. Vol 450, pp. 494-496. 223.Daar AS, Berndtson K, Persad D, Singer PA. How can developing countries harness biotechnology to improve health? BMC Public Health 2007, 7:346 doi:10.1186/1471-2458-7-346. 224.Hugo Statement on Pharmacogenomics (PGx): Solidarity, Equity and Governance. Genomics, Society and Policy. (3)1: 44-47. (2007) ISSN: 1746-5354 225.Singer PA, Court EB, Bhatt A, Frew SE, Greenwood H, Persad DL, Salamanca-Buentello F, Séguin B, Taylor AD, Thorsteinsdottir H and Daar AS. Applying Genomics-related Technologies for Africa’s Health Needs. African Journal of Medicine and Medical Sciences. 2007; 36. Suppl: 7-14 226.Masum H, Daar AS, Albader S, Shah R, and Singer P. Accelerating Health Product Innovation in Sub-Saharan Africa. Innovations (MIT Press). Vol 2 (4) pp. 151-171. Fall 2007. 227.Emerson CI, Daar AS. Defining Conscience and Acting Conscientiously. The American Journal of Bioethics. 2007 Dec; 7 (12): 19-21 228.Frew S, Sammut S, Shore A, Ramjist J, Al-Bader S, Rezaie R, Daar AS, Singer PA. Chinese health biotech and the billion-patient market. Nature Biotechnology. 26, 37-53 (2008). 229.Seguin B, Hardy B, Singer PA, Daar AS. Bidil: Recontextualizing the Race Debate. The Pharmacogenomics Journal. January 2008 8(3): 169-173 230.Séguin, B., Hardy, B. J., Singer, P. A. & Daar, A. S. Genomic medicine and developing countries: creating a room of their own. Nature Rev. Genet. 9, 487–493 (2008). 231.Land WG, Gutmann T, Daar AS. Emerging Science, Emerging Ethical Issues: Who should Fund Innate Alloimmunity-Supressing Drugs? Acta Chir Belg, 2008, 108, 73-82 232.Singh Jerome, Daar AS. The 20-year African biotech plan. Nature Biotech. 2008 March Vol 26 (3) pp. 272-274. 34
    • Curriculum Vitae, Daar AS 233.Cohen ER, Masum H, Berndtson K, Saunders V, Hadfield T, Panjwani D, Persad DL, Minhas GS, Daar AS, Singh JA, Singer PA. Public engagement on global health challenges. BMC Public Health. 2008 May 20;8:168. 234.Rezaie R, Frew SE, Sammut SM, Maliakkal MR, Daar AS, Singer PA. Brazilian health biotech--fostering crosstalk between public and private sectors. Nature Biotechnol. 2008 Jun;26(6):627-44. 235.Lander B, Thorsteinsdóttir H, Singer PA, Daar AS. Harnessing stem cells for health needs in India. Cell Stem Cell. 2008 Jul 3;3(1):11-5. 236.Hotez PJ, Daar AS (2008) The CNCDs and the NTDs: Blurring the Lines Dividing Noncommunicable and Communicable Chronic Diseases. PLoS Negl Trop Dis 2(10): e312. doi:10.1371/journal.pntd.0000312 (October 29, 2008) 237.Daar AS, Whyte SR, Abdullah MS, Ching-Li H, Hoffman SL, Martine Berger; TDR Thirty Years On: Taking Stock and Envisioning the Future for the Special Programme for Research and Training in Tropical Diseases. PLoS Negl Trop Dis 2(11): e314. doi:10.1371/journal.pntd.0000314 (November 25, 2008) 238.Béatrice Séguin Billie-Jo Hardy, Peter A. Singer, and Abdallah S. Daar. Human Genomic Variation Initiatives in Emerging Economies and Developing Countries. Nature Rev. Genet. 9 (Suppl), October (2008). 239.Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Genomics, public health, and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nature Rev. Genet. 9 (Suppl), October (2008) 240.Hardy, B., Séguin, B, Singer, P. A., Mukerji, M., Brahmachari, S. K. & Daar, A. S. From diversity to delivery: the case of the Indian Genome Variation initiative. Nature Rev. Genet. 9 (Suppl), October (2008). 241.Hardy, B., Séguin, B, Ramesar, R., Singer, P. A. & Daar, A. S. South Africa: from species cradle to genomic application. Nature Rev. Genet. 9 (Suppl), October (2008). 242.Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Universal health care, genomic medicine and Thailand: investing in today and tomorrow. Nature Rev. Genet. 9 (Suppl), October (2008) 243.Hardy, B. Seguin, F. Goodsaid, G. Jimenez-Sanchez, P. Singer, A. Daar The next steps for genomic medicine: challenges and opportunities for the developing world. Nature Rev. Genet. 9 (Suppl) October 2008 244.Z. R.S. Rosenberg-Yunger, A. S. Daar, P. A. Singer, D.K. Martin Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada. Health Policy 87 (2008) 359-368 245.Timothy Caulfield, Stephanie M Fullerton, Sarah E Ali-Khan, Lauara Arbour, Esteban G Burchard, Richard S Cooper, Billie-Jo Hardy, Simrat Harry, Robyn Hyde-Lay, Jonathan Kahn, Rick Kittles, Barbara A Koenig, Sandra S-J Lee, Michael Malinowski, Vardit Ravitsky, Pamela Sankar, Stephen W Scherer, Beatrice Seguin, Darren Shickle, Guilherme Suarez-Kurtz and Abdallah S Daar. Race and ancestry in biomedical research: exploring the challenges, 35
    • Curriculum Vitae, Daar AS inaugural issue of Genome Medicine, (launched at the American Society of Human Genetics 2008 Meeting in Philadelphia (November 11-15, 2008) 250. Peter A Singer and Abdallah S Daar with Sara Al-Bader, Ronak Shah, Ken Simiyu, Ryan E Wiley, Pamela Kanellis, Menaka Pulandiran and Marilyn Heymann: Commercializing African health research: building life science convergence platforms-Global Forum Update on Research for Health Volume 5 (October 2008) 251. Sheila Kamunyori, Sara Al-Bader, Ronak Shah, Ken Simiyu, Peter A. Singer, Abdallah S. Daar Accelerating African Health Innovation, Africa Journal (in press) Book Chapters 1. Fabre JW, Daar AS. The expression of normal epithelial membrance antigens on human colorectal and breast carcinomas: Demonstration of hitherto unrecognised heterogeneity within and between tumours. In: Burchiel EW, Rhodes BA, eds. Radioimmunoimaging and Radioimmunotherapy. New York: Elsevier Science Publishing, 1983, pp. 143-57. 2. Daar AS, Lennox ES. Tumour markers and antigens. In: Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publications, 1987, pp.1-26. 3. Daar AS. Monoclonal antibodies: Concepts and applications in cancer research and clinical oncology. In: Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publications, 1987, pp.93-114. 4. Daar AS. Plasma membrane molecular structure, differentiation antigens and the malignant phenotype: Tumour markers in context. In: Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publications, 1987, pp.27-66. 5. Daar AS. Introduction and overview of chapters. In: Daar AS, ed. Tumour Markers in Clinical Practice: Concepts and Applications. Oxford: Blackwell Scientific Publications, 1987, pp.xv-xx. 6. Dalchau R, Daar AS, Fabre JW. The human Thy-1 analogue. In: Reif AE, Schlesinger M, eds. Thy-1. New York: Marcel Decker, 1987, pp. xxx. 7. Daar AS, Pingle A. Transplantation in the lower Arabian Gulf: Current status and future prospects. In: Hassaballah M, ed. Recent Aspects of the Use of Cyclosporine in Renal Transplantation. Amsterdam: Excerpta Medica, 1987, pp. 12-19. 8. Daar AS. Renal transplantation in developing countries. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice, 3rd edition. Philadelphia: W.B. Saunders, 1988, pp. 709-35. 9. Daar AS. Current practice and the legal, ethical, and religious status of post mortem organ donation in the Islamic World. In: Land W, Dossetor JB, eds. Organ Replacement Therapy: Ethics, Justice and Commerce. Berlin: Springer-Verlag, 1991, pp. 291-299. 10. Daar AS. Rewarded gifting and rampant commercialism in perspective: Is there a difference? In: Land W, Dossetor JB, eds. Organ Replacement Therapy: Ethics, Justice and Commerce. Berlin: Springer-Verlag, 1991, pp. 181-189. 36
    • Curriculum Vitae, Daar AS 11. Daar AS. Transplantation in developing countries: Economic aspects. In: Ahmed M, Blanchard RJW, Eklof B, Harrison TS, Moazam F, Suleman SK, Talati J, Tibblin S, eds. Surgery for All: A View From the Developing World. Ferozsons: Lahore, 1992. 12. Daar AS. Renal transplantation in developing countries. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice, 4th edition. Philadelphia: W.B. Saunders, 1992; pp. 478-503. 13. Grant CS, Daar AS. Transfusion for Elective Surgery. In: Essien E, ed. Handbook of Blood Transfusion Medicine in Oman. Muscat: Ministry of Health, 1994. 14. Daar AS, Grant CS. Transfusion in surgical emergencies. In: Essien E, ed. Handbook of Blood Transfusion Medicine in Oman. Muscat: Ministry of Health, 1994. 15. Mabogunje OA, Grant CS, Daar AS. Biliary and intestinal trematodes. In: Morris PJ, Malt RA. Oxford Textbook of Surgery. Oxford: Oxford University Press, 1994, pp. 2569-76. 16. Grant CS, Daar AS. Typhoid fever and other salmonella infections. In: Morris PJ, Malt RA. Oxford Textbook of Surgery. Oxford: Oxford University Press, 1994, pp. 2478-9. 17. Mabogunje OA, Daar AS. Ascariasis and other intestinal nematode infections. In: Morris PJ, Malt RA. Oxford Textbook of Surgery. Oxford: Oxford University Press, 1994, pp. 2500-7. 18. Daar AS. Schistosomiasis (bilharziasis). In: Morris PJ, Malt RA. Oxford Textbook of Surgery, Oxford: Oxford University Press, 1994, pp. 2511-23. 19. Daar AS. Living-organ donation: Time for a donor charter. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1994. Los Angeles: University of California, Los Angeles Press, 1995, pp. 376-80. 20. Daar AS. The human body market -- a temptation? In: Club de la Transplantation, Paris. Transplantation et Societe. Paris: Janssen-Cilag, 1996. 21. Daar AS, Gutmann T, Land W. Reimbursement, "Rewarded gifting," financial incentives and commercialism in living organ donation. In: Collins GM, Dubernard JM, Land W, Persijn CG, eds. Procurement, Preservation and Allocation of Vascularised Organs. Dordrecht: Kluwer Academic Publishers, 1997, pp. 301-16. 22. Habgood The Right Reverend Lord, Spagnolo AG, Daar AS. Religious views on organ and tissue donation. In: Chapman JR, Deirhoi M, Wight C. Organ and Tissue Donation for Transplantation. London: Arnold, 1997, pp. 23-33. 23. Daar AS. Paid organ donation: Towards an understanding of the issues. In: Chapman JR, Deirhoi M, Wight C. Organ and Tissue Donation for Transplantation. London: Arnold, 1997, pp. 46-61. 24. Daar AS. A premise and value-based teleological approach to cope with the challenges of genetic engineering. Loccumer Protokolle 1998;59/97:103-10. 25. Daar AS. Xenotrasplante y religión: las principales religiones monoteístas. (Xenotransplantation and religion: The major monotheistic religions.) In: Santiago-Delphin EA, 37
    • Curriculum Vitae, Daar AS Ruiz-Speare JO, eds. Trasplante de Órganos, 2a. Edición. Mexico: JGH Editores, 1999, pp. 181-5. (In Spanish.) ISBN 970-681-007-2 26. Daar AS. Xenotransplantation: Science, Risk and International Regulatory Efforts. In: Caulfied T, Williams-Jones B, eds. The Commercialization of Genetic Research: Legal, Ethical and Policy Issues. Dordrecht: Kluwer Academic/Plenum Publishers, 1999, pp. 129-55. ISBN 0-306-46287-7 27. Marshall PA, Daar AS. Ethical Issues in Human Organ Replacement: A Case Study from India. In: Whiteford L, Manderson L, eds. Global Health Policy, Local Realities: The Fallacy of the Level Playing Field. Boulder, Colorado: Lynne Rienner Publishers, Inc., 2000, pp. 205-32. 28. Grant CS, Huizinga WJK, Daar AS. Chapter 47.1.2. Typhoid fever and other salmonella infections. In: In: Morris PJ, Wood WC, eds. Oxford Textbook of Surgery, 2nd edition. Oxford: Oxford University Press, 2000, pp. 3230-7. ISBN 0-19-262884-4 29. Daar AS, Scrimgeour EM. 47.2.2. Schistosomiasis (bilharziasis) In: In: Morris PJ, Wood WC, eds. Oxford Textbook of Surgery, 2nd edition. Oxford: Oxford University Press, 2000, pp. 3278-92. ISBN 0-19-262884-4 30. Huizinga WJK, Grant CS, Daar AS. Chapter 47.2.4. Hydatid disease. In: Morris PJ, Wood WC, eds. Oxford Textbook of Surgery, 2nd edition. Oxford: Oxford University Press, 2000, pp. 3298-3305. ISBN 0-19-262884-4 31. Mabogunje OA, Daar AS. Chapter 47.2.5. Ascariasis and other intestinal nematode infections. In: Morris PJ, Wood WC, eds. Oxford Textbook of Surgery, 2nd edition. Oxford: Oxford University Press, 2000, pp. 3305-13. ISBN 0-19-262884-4 32. Mabogunje OA, Grant CS, Daar AS. Chapter 47.2.6. Biliary and intestinal trematodes. In: Morris PJ, Wood WC, eds. Oxford Textbook Surgery, 2nd edition. Oxford: Oxford University Press, 2000, pp. 3313-21. 33. Daar AS, Aluwihare A. Chapter 47.8. Surgery of advanced disease and late presentation. In: Morris PJ, Wood WC, eds. Oxford Textbook of Surgery, 2nd edition. Oxford: Oxford University Press, 2000, pp. 3371-80. ISBN 0-19-262884-4 34. Daar AS, Rizvi SA, Naqvi SA. Chapter 47.9. Surgery with limited resources. In: Morris PJ, Wood WC, eds. Oxford Textbook of Surgery, 2nd edition. Oxford: Oxford University Press, 2000, pp. 3381-95. ISBN 0-19-262884-4 35. Daar AS, Singer PA. Chapter 1.14.5.1 Bioethics and Biotechnology : Encyclopaedia of Life Support Systems. UNESCO, 2001 36. Dossetor JB, Daar AS. Chapter 41. Ethics of Transplantation: Allotransplantation and Xenotransplantation. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice, 5th edition. Philadelphia: W.B. Saunders, 2001, pp. 732-44. ISBN 0-7216-8297-9 37. Moosa MR, Walele AA, Daar AS. Chapter 38. Renal Transplantation in Developing Countries. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice, 5th edition. Philadelphia: W.B. Saunders, 2001, pp. 659-92. ISBN 0-7216-8297-9 38. Daar AS, Merali Z. Infertility and social suffering: the case of Assisted Reproductive Technologies (ART) in developing countries. In: Vayena E, Rowe PJ, Griffin PD, eds. 38
    • Curriculum Vitae, Daar AS Current Practices and Controversies in Assisted Reproduction. Geneva: World Health Organization, 2002, pp. 15-21. ISBN 92-4-159030-0 39. Daar AS, Singer PA. 6.4.1 Biotechnology and Bioethics. In: Global Perspectives of Health, Encyclopedia of Life Support Systems (EOLSS), Eolss Publishers, Oxford, UK, 2002, http://www.eolss.net. 40. Thorsteinsdóttir H, Daar AS, Smith RD, Singer PA. Genomics knowledge. In: Smith RD, Beaglehole R, Woodward D, Drager N, eds. Global Public Goods for Health: a Health Economic and Public Health Perspective. New York: Oxford University Press, 2003, pp. 142-63. 41. Thorsteinsdóttir H, Daar, AS, Smith RD, Singer PA. Do Patents Encourage or Inhibit Genomics as a Global Public Good? In: Knoppers BM, Caulfield TA, Laberge C, eds. Populations and Genetics: Legal and Socio-Ethical Perspectives. Leiden/Boston: Martinus Nijhoff Publishers, 2003, pp. 487-504. 42. Daar AS, Chapman LE. Xenotransplantation. In: Post SG, ed. Encyclopedia of Bioethics, 3rd edition, Volume 5. New York: MacMillan Reference USA, 2004, pp. 2601-12. ISBN 0-02-865779-9 43. Daar AS, Singer PA. Harnessing Genomics for Global Health: The Role of Higher Education. In: Jones GA, McCarney P, Skolnik ML, eds. Creating Knowledge, Strengthening Nations: The Changing Role of Higher Education. Toronto: University of Toronto Press, in press. 44. Gutmann T, Daar AS, Sells RA, Land W. Preface. In: Gutmann T, Daar AS, Sells RA, Land W, eds. Ethical, Legal and Social Issues In Organ Transplantation. Munich: PABST Science Publishers, Lengerich. pp. 13-14. ISBN (USA) 1-59326-063-6/Europe ISBN 3-89967-017-5 45. Daar AS. Money and organ procurement: narratives from the real world. In: Gutmann T, Daar AS, Sells RA, Land W, eds. Ethical, Legal and Social Issues In Organ Transplantation. Munich: PABST Science Publishers, Lengerich. pp. 298-314. ISBN (USA) 1-59326-063-6/Europe ISBN 3-89967-017-5 46. Daar AS. Regenerative: a taxonomy for addressing ethical, legal and social issues. medicine today. In: Gutmann T, Daar AS, Sells RA, Land W, eds. Ethical, Legal and Social Issues In Organ Transplantation. Munich: PABST Science Publishers, Lengerich. pp. 368-377 ISBN (USA) 1-59326-063-6/Europe ISBN 3-89967-017-5 47. Singer PA, Goertzen H, Taylor AD, Dowdeswell E, Daar AS. Energizing Canadian Foreign Policy Through Science and Technology Innovation. In Carment D, Hampson F, Hillmer N, eds. Canada Among Nations 2004: Setting Priorities Straight. McGill-Queen’s University Press, 2005. pp 225-243. ISBN 0-773-52837-7 48. Daar AS, Acharya T, Filate I, Thorsteinsdóttir H, Singer PA. Beyond GM Foods: Genomics, Bioethics and Global Health Equity. In: Thiele F, Ashcroft R, eds. Bioethics in a Small World. Berlin: Springer-Verlag, 2005. pp. 35-44. ISBN 3-540-23595-7 49. Daar AS, Singer PA. Biotechnology and Human Security. In: Helsinki Process Secretariat, ed. Helsinki Process Papers on Human Security. Helsinki, 2005. pp. 120-62. ISBN 951-724-473-8 39
    • Curriculum Vitae, Daar AS 50. Nixon S, Upshur R, Robertson A, Benatar S, Thompson A, Daar A. Public Health Ethics. In Bailey T, Caulfield T, Ries NM, eds. Public Health Law, Ethics and Policy. Markham: LexisNexis Butterworths, 2005. pp. 39-58. 51. Daar AS, Singer PA. Pharmacogenetics and geographical ancestry: Implications for drug development and global health. In: Matlin S, ed. Global Forum Update on Research for Health, Volume 2: Poverty, Equity and Health Research. London: Pro-Book Publishing, 2005. pp. 188-25. 52. Castle D, Cline C, Daar AS, Tsamis C, Singer PA. Nutrients and Norms: Ethical Issues in Nutritional Genomics. In Kaput J, Rodriguez RL, eds. Nutitional Genomics: Discovering the Path to Personlized Nutrition. John Wiley & Sons Inc., 2006. pp. 419-434. ISBN 0-471-68319-1 53. Acharya T, Thorsteinsdóttir H, Singer PA, Daar AS. Who Will Live in the ‘House of Genomics?’ Report on Forum on Emerging Infections. In. Knobler SL, Burroughs T, Mahmoud A, Lemon SM, eds. Ensuring an Infectious Disease Workforce: Education and Training Needs for the 21st Century. Washington: National Academies Press, 2006. pp. 67-75. ISBN 0-309-10010-0 54. Wright L, Ross K, Daar AS. Organ Transplantation. In: Singer P, Viens A, eds. The Cambridge Text of Bioethics. Cambridge University Press. 2008. pp. 145-152. ISBN 978-0-521-87284-3 55. Greenwood H, Daar AS. Regenerative Medicine. In: Singer P, Viens A, eds. The Cambridge Text of Bioethics. Cambridge University Press. 2008. pp. 153-159. ISBN 978-0-521-87284-3 56. Daar AS. Introduction. ”Genetics and Biotechnology”. In: Singer P, Viens, A, eds. The Cambridge Text of Bioethics. Cambridge University Press. 2008. pp. 143-144. ISBN 978-0-521-87284-3 57. Daar AS, Bakdash T, Khitamy AB, “Islamic Bioethics for Physicians Practising in the West”,. In: Singer P, Viens AM, eds. The Cambridge Text of Bioethics. Cambridge University Press. 2008. pp. 408-415. ISBN 978-0-521-87284-3 58. Séguin B, Essajee S, Dabu A, Jimenez-Sanchez G, and Daar AS. Implications of Human Genomic Variation Studies and Pharmacogenomics for Global Health. In ‘Pharmacogenomics in Admixed Populations’ Medical Intelligence Unit, Landes Bioscience (2007) pp 198-207 59. Court EB, Salamanca-Buentello F, Singer PA, Daar AS. Public Engagement and Education for Ethics in Nanotechnology. In “Nanotechnologies, Ethics and Politics. Ed. Henk Ten Have. UNESCO Ethics Series. ISBN 978-92-3-104051-1. 60. Land WG, Guttmann T, Daar AS. Emerging Science, Emerging Ethical Issues: Who should Fund Innate Alloimmunity-Supressing Drugs?. In Weimar W, Bos MA, Busschbach J, eds. Organ Transplantation: Ethical, Legal and Psychosocial Aspects – Towards a Common European Policy. PABST Science Publishers, 2008. pp. 516-528. ISBN 978-3-89967-415-6 61. Wright L, Campbell M, Daar AS. Ethics of Transplantation. In: Knechtle S, Morris PJ, eds. Kidney Transplantation, 6th Edition. WB Saunders. (In Press) 40
    • Curriculum Vitae, Daar AS 62. Singer PA, Panjwani D, Frew S, Greenwood H, Persad DL, Salamanca-Buentello F, Séguin B, Taylor AD, Thorsteinsdòttir H, Daar AS, “The Role of Emergent Technologies in the Health of the Developing World’. BiovisionAlexandria Proceedings. (In Press) 63. Nixon S, Upshur R, Robertson A, Benatar S, Thompson A, Daar A. Public Health Ethics. In Bailey T, Caulfield T, Ries NM, eds. Public Health Law and Policy in Canada. 2nd Edition. Markham: LexisNexis Butterworths (In Press). 64. Sreenavasan G, Daar AS. Health Inequalities. Health Care Ethics. In “An Era of Globalisation”. Eds: Ruth Chadwick, Henk ten Have, Eric Meslin. Sage. (In Press). Reports and Similar Publications 1. Daar AS, Sells RA. The Problems Of Paid Organ Donation In India. Report on behalf of the Ethics Committee of the Transplantation Society to the President and Council of the Transplantation Society, 13th International Congress, Transplantation Society. San Francisco, USA, 1990. 2. Daar AS. 40 Years of Organ Transplantation: Successes and Challenges. International Conference of Medical Parliamentarians. Bangkok, Thailand, 1994. 3. Daar AS, Al Busaidi Q, Marhuby H, Mohsin N. Sultanate of Oman National Transplant Programme -- A Joint Proposal. Muscat: Ministry of Health, 1995. 4. Daar AS. Clinical Curriculum Handbook, 3rd edition. Muscat: College of Medicine, Sultan Qaboos University, 1997. 5. Daar AS. Xenotransplantation -- Predicting the response of recipients and the public. Discussion Document, World Health Organization Consultation on Xenotransplantation. Geneva, Switzerland, 1997. 6. Daar AS. Draft WHO Guiding Principles: Recommendations to WHO and Member Countries. Presented to the Advisory Committee on Health Research, World Health Organization. Geneva, Switzerland, 1998. Also presented for discussion at the 52nd World Health Assembly. Available at http://www.who.int/wha-1998/WHA99/PDF99/ew12.pdf 7. Daar A, Mattei J-F. Medical genetics and biotechnology: Implications for public health, document WHO/EIP/GPE/00.1. Annex 1 of the Report of the informal consultation on Ethical Issues in Genetics, Cloning and Biotechnology: Possible Future Directions for WHO. Geneva: World Health Organization, 1999. Referenced in Doc. No. WHA53/15, Report on Cloning, WHO Director-General to the 53rd World Health Assembly, Geneva, 2000. Available at http://www.who.int/wha-1998/WH00/PDF/ea15.pdf 8. World Health Organization. [Daar AS, chairman.] Report of the WHO Consultation on Xenotransplantation. Doc. No. WHO/EMC/ZOO/98.2. Geneva, Switzerland, 1997. Available at http://www.who.int/emc-documents/zoonoses/docs/whoemczoo982.pdf 9. Baird P, Berg K, Daar AS, Modell B, Verma I, Williamson R. Report of the Expert Group Consultation on Developments in Human Genetics. Geneva: World Health Organization, July 2000. http://www.who.int/ncd/hgn/Statement.pdf. 41
    • Curriculum Vitae, Daar AS 10. Daar AS. Raising Our Sights Planning Committee Report. Muscat: College of Medicine, Sultan Qaboos University, 2001. 11. Daar AS, Singer PA. Expert Position Paper. Hearing on ACHR Special Report on Genomics and World Health. Geneva, June 2001. 12. Daar AS. Expert position paper. Perspective of the Eastern Meditearranean Region of WHO. WHO ACHR report on Genomics and World Health. Bangkok. July 2001. 13. World Health Organization. Report on “Collaboration in Medical Genetics” See report at http:// www.who.int/ncd/hgn/toronto_report1.pdf (part of the writing team) 14. Acharya T, Daar AS, Thorsteinsdóttir H, Singer PA, Quach U, Salamanca-Buentello F. Global Bioethics as the Foundation for Knowledge Societies: The Example of Genomics. Background Paper for UNESCO World Report on Knowledge Societies, in press. 15. Mahroum S, Eldridge C, Daar AS. Diaspora Options: How Developing Countries Could Benefit From Their Emigrant Populations. Paper prepared for two working groups (Africa and Innovation) of the Joint Learning Initiative on Human Resources for Health and Development, in press. 16. White Paper on Energizing Canadian Foreign Policy through Science and Technology Innovation. Prepared by the Joint Centre for Bioethics in association with the National Research Council of Canada (NRC) and International Research and Development Centre (IDRC). 17. Institute of Medicine National Research Council of the National Academies. A Report of a Workshop: An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks. 2005. See p. 84-5. 18. Daar AS, Dowdeswell E, Panjwani D, Persad DL, Singer PA. A Report of the Workshop: “The Global Bargain for Biosecurity”, at the New York Academy of Sciences. DNA for Peace: Reconciling Biodevelopment and Biosecurity. February 2006. 19. Daar AS (Chair), Abdallah MS, Ching-li H, White SR, Hoffman SL. Fourth External Review of the UNICEF/UNDP/WORLD BANK/WHO: Special Programme for Research and Training in Tropical Diseases (TDR) Document No. TDR/JCB(29)/06.7. May 2006. The report is accessible at: http://www.who.int/tdr/publications/publications/pdf/erc4_full.pdf 20. Juma C (Co-Chair), Serageldin I (Co-Chair), Daar AS et al. “Freedom to Innovate: Biotechnology in Africa’s Development. Report of the High-Level African Panel on Modern Biotechnology. African Union. January 2007 Weblink: http://www.nepadst.org/doclibrary/pdfs/biotech_africarep_2007.pdf 21. Innovative Health Service Delivery Models for Low and Middle Income Countries. Onil Bhattacharyya, Anita McGahan,Peter A. Singer, Abdallah Daar, Report prepared for the Rockefeller Foundation 42
    • Curriculum Vitae, Daar AS Policy Statements of the Ethics Committee of The (International) Transplanation Society (Member) and other Transplant Societies 1. Ethics Committee of the Transplantation Society. Revised Ethics Guidelines. Transplantation Society Bulletin 1994;2:22-3. 2. Ethics Committee of the Transplantation Society. Policy Statement: Concerning death, monitoring of tissue and organ transplantation; and commercial trafficking in tissues and organs. Clinical Transplantation 1995;4:354. 3. Sheil AGR, Barker CF, Butt KMH, Cosimi AB, Daar AS, Santiago-Delpin EA, Dohi K, Morris PJ, Rizvi AH. [Ethics Committee of the Transplantation Society.] The Transplantation Society and Xenotransplantation. Transplantation Society Bulletin 1997;6:11-4. 4. Seoul Declaration on Brain Death. Asian Society of Transplantation, 1996. See: Seoul Declaration on Brain Death. International Digest of Health Legislation 1997;48(2):229. 5. Shiel R, on behalf of the Ethics Committee of the Transplantation Society. Executed prisoners in China, response to David Rothman. Sciences (New York Academy of Sciences) May/June 1998. 6. The Ethics Committee of the Transplantation Society. Consensus statement of the Amsterdam Forum on Care of the Live Kidney Donor. Transplantation 2004 Aug 27;78(4):491-2. Statements of the Ethical, Legal and Social Issues Committee of the Human Genome Organization (HUGO) Membership: Bartha Maria Knoppers, Ruth Chadwick, Hiraku Takebe, Michael Kirby, Kare Berg, RenZong Qiu, Darryl Macer, José-Maria Cantu, Dorothy C. Wertz, Thomas H. Murray, Abdallah S. Daar, Ishwar Verma, and Eve Marie Engels. 1. Statement on Benefit Sharing. Released at the Human Genome Meeting. Vancouver, British Columbia, Canada, April 2000. Available at http://www.gene.ucl.ac.uk/hugo/benefit.html and http://www.biol.tsukuba.ac.jp/~macer/benshare.html and Eubios Journal of Asian and International Bioethics 2000;10:70-2., also: Science 2000;290:49., and Community Genetics 2000;3:88-92. 2. Statement on Gene Therapy. Ethics Committee, Human Genome Organization (Knoppers BM, Chadwick R, Takebe H, Kirby M, Berg K, RenZong Q, Macer D, Cantu J-M, Wertz DC, Murray TH, Daar AS, Verma I, Engels EM). HUGO. Edinburgh, April 2001. Available at http:// www.biol.tsukuba.ac.jp/~macer/genther.htm. 3. Statement on Genomic Databases. Ethics Committee, Human Genome Organization (Knoppers BM, Chadwick R, Takebe H, Kirby M, Berg K, RenZong Q, Macer D, Cantu J-M, Wertz DC, Murray TH, Daar AS, Verma I, Engels EM). HUGO Human Genome Organization. 2002/3. 4. Statement on Stem Cells. Ethics Committee, Human Genome Organization (Chadwick R, Kirby M, Berg K, Macer D, Cantu J-M, Murray TH, Daar AS, Verma I, Kato K). HUGO Human Genome Organization. 2004. 5. Hugo Statement on Pharmacogenomics (PGx): Solidarity, Equity and 43
    • Curriculum Vitae, Daar AS Governance. Genomics, Society and Policy. (3)1: 44-47. (2007) ISSN: 1746-5354 Editorials, Op-eds, Commentaries 1. Daar AS. Leucocyte response and graft loss in acute renal allograft rejection. The Digests, Illinois, June 1978. 2. Daar AS, Smith JC. Myths and fallacies in surgery. Oxford Medical School Gazette 1982;34:27. 3. Daar AS, Kazim E. Overseas doctors training scheme of Royal College of Surgeons, England. [Editorial.] Emirates Medical Journal 1986;5:1-3. 4. Daar AS. Establishment of renal transplantation in developing countries. [Editorial.] Emirates Medical Journal 1986;4:4-7. 5. Daar AS. Elintensiirrot Lahi-idassa -- eettisia kysymyksia. Suomen Laakarilehti 1989;12:1248-9. 6. Daar AS. Renal Transplantation in Islam: The Basis for Recent Legal Opinions. [Editorial.] Emirates Medical Journal 1990;8:1-3. 7. Daar AS. Brain death and organ transplantation. Current Anthropology 1994 Jun;35(3):245-6. (Ohnuki-Tierney E, Angrosino MV, Becker C, Daar AS, Funabiki T, Lorber MI. Brain death and organ transplantation: cultural bases of medical technology. Current Anthropology 1994 Jun;35(3):233-54.) 8. Daar AS. Societal Issues in Organ Transplantation. Annals of Transplantation 1998;3(2). (Guest Editor). 9. Daar AS. Beyond the Georgetown Mantra: Review of Training Manual on Ethical and Human Rights Standards for Health Care Professionals. Health and Human Rights 2000;5(1):186-92. 10. Daar AS, Singer PA. Drawing the line on cloning. [Commentary.] National Post Online 2001 May 4. 11. Singer P, Daar A, Dowdeswell E. Gateway to global health. [Commentary.] The Globe & Mail 2001 Oct 29; p. A15. 12. Daar AS. Failure of clinical ethics to deliver on its promise. (Clinical ethics revisited: Response.) BioMedCentral Medical Ethics 2001;2:E2. Epub 2001 Apr 26. (In Clinical ethics revisited: responses. Benatar SR, Bhutta ZA, Daar AS, Hope T, MacRae S, Roberts LW, Sharpe VA. 13. Daar AS, Singer PA. Killing with Kindness? Project Syndicate 2002 Feb. http://www.project- syndicate.cz/series/series_text.php4?id=790 (online publication). 14. Daar AS, Singer PA. Human capital is key to research ethics. SciDev.Net 2002 Apr 25. 15. Caulfield T, Daar AS, Knoppers BM, Singer PA. MPs have the wrong focus. The Globe and Mail 2002 May 2. 44
    • Curriculum Vitae, Daar AS 16. Daar AS, Caulfield T, Knoppers BM, Singer PA. Ban cloning, not its life-saving cousin. Globe and Mail 2002 May 9; p. A21. 17. Singer PA, Daar AS. Of genetic mice and men. The Globe & Mail 2002 Dec 16; p. A17. 18. Singer PA, Daar AS. On the Eve of a Cloning Backlash. National Post 2002 Dec 30. 19. Caulfield T, Daar AS, Singer PA, Knoppers B, Castle DGAC, Forbes Ron. Not All Cloning is Alike: MP’s Must Not Let Outrageous Claims of Raelians Drive National Policy Development. The Hill Times 2003 Feb 24. 20. Daar AS, McKneally MF. Ethical, Social, and Policy Issues: Introduction. World Journal of Surgery 2003;27:928-9. 21. Daar AS. Invited Commentary. World Journal of Surgery 2003;27:934-5. 22. Singer P, Daar A. We should clone this U.K. policy. Globe & Mail 2004 Aug 12; p. A17. 23. Matas AJ, Schnitzler M, Daar AS. Payment for Living Kidney Donors (Vendors) is Not an Abstract Ethical Discussion Occurring in a Vacuum. [Editorial Response.] American Journal of Transplantation 2004 Aug;4(8):1380-1. 24. Daar AS, Singer PA. Race: A risk genetics must run. Globe & Mail 2005 Jun 25; p. F7. 25. Daar AS et al. In Support of Academic Freedom [Editorial Response]. Science. June 2007 (316) 1840 26. Berndtson Kathryn, Daar AS. "Faithfully fighting malaria together". Globe and Mail. December 23, 2007 Correspondence in Scientific Journals 1. Daar AS. Xenotransplants: Proceed with caution. Nature 1998 Mar 5;392:11. 2. Daar AS. Use of renal transplants from living donors: Practice is essential to alleviate shortage of organs. British Medical Journal 1999 Jun 5;318(7197):1553. 3. Daar AS. Renal transplantation from living donors -- Additional justification. British Medical Journal 1999;318. Pubmed index entry as: Daar AS. Use of renal transplants from living donors -- Practice is essential to alleviate shortage of organs. British Medical Journal 1999;318:1553. 4. Daar AS. Xenotransplantation: Three questions to advance the discourse. British Medical Journal 2000 Apr 29. Available at: http://www.bmj.com/cgi/eletters/320/7238/868#EL1. 5. Singer PA, Daar AS. Biotech gap between North and South -- Response. Science 2001;294:2290. 6. Daar AS. (Online correspondence - response). Pharmacogenetics, Pharmacogenomics and Population Admixture: Implications for Drug Development and Prescription. Nature Reviews 45
    • Curriculum Vitae, Daar AS Genetics 2005 Mar. Available online at http://www.nature.com/nrg/journal/v6/n3/corres/nrg1559_fs.html. 7. Tracy CS, Upshur RE, Daar AS. Avian influenza and pandemics. New England Journal of Medicine 2005 May 5;352(18):1928. 8. Daar AS. Biotech can stop bioterror. New Scientist. Vol 189, No. 2541, pp 7-7, 2006 9. Mackie JE, Taylor AD, Finegold DL, Daar AS, Singer PA. Authors’ Reply to enquiry from Boyd and Rogers on “Lessons on Ethical Decision Making from the Bioscience Industry”. PLoS Medicine. June 2006; 3(6): e288 10. Torsten W, Agre P, Arrow KJ, Atiyah M, Brézin E, Charfi FF, Cohen-Tannoudji C, Daar AS, Jacob F, Kahneman D, Yuan Tseh L, Nicolaisen I, Nusseibeh S, Reuter H, Shoham Y, Sulston J, Walzer M,Yaari M. The Israeli-Palestinion Science Organization. Letter. Science. Vol 315. January 5, 2007 D. INVITED LECTURES (from 1995, partial list) 1. 7th International Conference on Jewish Medical Ethics, Hebrew Academy of San Francisco, February 1995. 2. Securing Bodily Integrity for the Socially Disadvantaged: Strategies for Controlling the Traffic in Organs for Transplantation. Bellagio, Italy, September 1995. 3. 8th International Conference on Jewish Medical Ethics, Hebrew Academy of San Francisco, February 1996 (participant). 4. 2nd International Symposium on Urology, Nephrology and Transplantation, Sindh Institute of Urology and Transplantation. Karachi, Pakistan, March 1996. 5. British Transplantation Society/21st Anniversary of the Oxford Transplant Centre. Oxford/London, March 1996. 6. Commerce in Organs: Culture, Politics, and Bioethics in the Global Market, Department of Anthropolgy, University of California at Berkeley, April 1996. 7. Social Science Resarch Council. New York, April 1996. 8. Distinguished Foundation Visitor, Royal Australian College of Surgeons, May 1996. 9. University of Auckland, New Zealand, May 1996. 10. Otago University, New Zealand, May 1996. 11. University of Sydney, Australia, May 1996. 12. University of Brisbane, Australia, May 1996. 13. European Dialysis and Transplant Association Congress, Amsterdam, June 1996. 46
    • Curriculum Vitae, Daar AS 14. XVI International Congress of the Transplantation Society. Barcelona, Spain, August 1996. 15. Living Donor Renal Transplantation, University of Oslo. Oslo, Norway, September 1996. 16. 2nd International Congress on Dialysis in Developing Countries, Singapore, October 1996. 17. Bellagio Task Force Force on Transplantation, Bodily Integrity and the International Traffic in Organs, Italy, November 1996. 18. Arab Pediatric Nephrology Congress. Cairo, Egypt, December 1996. 19. European College of Transplantation, Munich, December 1996. 20. International Forum for Transplant Ethics, Seville, January 1997. 21. European College of Transplantation, Helsinki, March 1997. 22. South African Transplant Congress, South Africa, March 1997. 23. Louvain University, Belgium, April 1997. 24. European College of Transplantation, Helsinki, May 1997. 25. Society for Organ Sharing, Washington, July 1997. 26. Moderator, 37th World Congress of Surgery. Acapulco, Mexico, August 1997. 27. Second Meeting of the WHO Task Force on Organ Transplantation. Annecy, France, October 1997. 28. Genes the World Over, Evangelische Akademie Loccum, Germany, October 1997. 29. Chairman, Infectious Disease Prevention and Ethical Considerations, WHO Consultation on Xenotransplantation, Geneva, October 1997. 30. 5th Congress of the Arab Nephrology and Kidney Transplantation Society. Beirut, Lebanon, November 1997. 31. 5th Congress of the Asian Society of Transplantation. Manila, Philippines, December 1997. 32. Session Chairman/Lecturer, OECD/New York Academy of Sciences Conference on Xenotransplantation, New York, March 1998. 33. Patron President, 2nd International Congress on Transplantation in Developing Countries, Taiwan, May 1998. 34. Festschrift for Professor Thomas Starzl. Buenos Aires, Argentina, May 1998. 35. Keynote Address, Foundation on Health Sciences. Madrid, Spain, June 1998. 47
    • Curriculum Vitae, Daar AS 36. 17th International Congress of the Transplantation Society. Montreal, Quebec, Canada, June 1998. 37. Congress on Commercialization of Genetic Research - Ethical, Legal and Policy Issues. Edmonton, Alberta, Canada, September 1998. 38. Festschrift for Professor Walter Land, University of Munich, October 1998. 39. Ellen Picard Lecturer, University of Alberta Health Law Institute. Edmonton, Alberta, Canada, January 1999. 40. Seminar on "Paid Organ Donation," University of Alberta Health Law Institute. Edmonton, Alberta, Canada, January 1999. 41. Multicultural Ethical Issues in Transplantation, Institute of Medicine, Law, and Bioethics, University of Manchester and Liverpool. Manchester, England, February 1999. 42. Ethical and Legal Aspects of Xenotransplantation, Evangelisce Academy Loccum. Loccum, Germany, February 1999 (Medizinische Hochschule Hannover) 43. 6th International Congress of the Asian Transplantation Society, Singapore, September 1999. 44. Planning Meeting, Ethics, Science and Governance. Ottawa, Ontario, Canada, May 1999. 45. Symposium (Festschrift) to honour Professor Walter Thiel, University of Basel, Switzerland, June 1999. 46. First Planning Meeting, International Project on Clinical Ethics, Amsterdam, July 1999. 47. Transplantation masterclass for PhD students, University of Groningen, Netherlands, September 1999. 48. International Consultation on Inter-religious Dialogue, University of Tuebingen, Germany, October 1999. 49. Expert Panels on "Ethical Issues in Genetics" and "Technical Innovations in Surgery: Facing the Ethical Challenges," American College of Surgeons, San Francisco, October 1999. 50. Jan Brod Lecturer, University of Oxford. Oxford, England, November 1999. 51. "Xenotransplantation: Risk, Ethics and Public Policy," Canadian Association for Clinical Microbiology and Infectious Diseases. Edmonton, Alberta, Canada, November 1999. 52. Consultation on "Ethical issues in genetics, cloning and biotechnology: Possible future directions for WHO," Discussion of the Daar/Mattei report and WHO's future direction in genetics and biotechnology, Geneva, December 1999. 53. "Xenotransplantation: Where do we go from here?," XI Walter Brandel Symposium, Italy, February 2000. 48
    • Curriculum Vitae, Daar AS 54. Rapporteur, "Ethical, Legal and Social Aspects of Technological Developments," Workshop on Genetic Testing -- Policy issues for the new millenium, OECD/Government of Austria. Vienna, Austria, February 2000. 55. Panelist on Ethical Issues, Workshop at Human Genome Meeting. Vancouver, British Columbia, Canada, April 2000. 56. Panelist, Developing a "Global Ethics" in Science -- Models and Challenges, Harvard Medical School. Cambridge, Massachusetts, June 2000. 57. Moderator and Panelist, Shaping a Global Ethic: Engaging the Public and Ensuring the Process is Legitimate, Boston University. Boston, Massachusetts, June 2000. 58. "The Genetics Revolution: Implications and Priorities for Developing Countries”, Consultation on Human Genetics. Geneva, Switzerland, July 2000. 59. Meech Lake International Initiative, The Hastings Center. Garrison, New York, July 2000. 60. Planning meeting for "Conference on Ethics and Health – Cross-Cultural Perspectives" held in Fall 2000, WHO/CIOMS/IOMS. Geneva, Switzerland, August 2000. 61. Conference on Human Cloning, EXPO 2000, Speyer Protestant Academie. Hanover, Germany, August 2000. 62. International Congress of the Transplantation Society. Rome, Italy, August/September 2000. 63. OECD Conference on Surveillance in Xenotransplantation. Paris, France, October 2000. 64. Hunterian Professor Lecture, Oxford University. Oxford, England, November 2000. 65. Initiative on involving the developing world in a discussion of the ethical implications of new technologies, Harvard University. Cambridge, Massachusetts, November 2000. 66. International Forum for Transplantation Ethics. Oxford, England, January 2001. 67. Keynote Address, Transplantation Society of Australia and New Zealand. Canberra, Australia, April 2001. 68. Recent International Bioethics Work in the Area of Genomics. Keynote Speaker, Common Law/ Pacific Rim Working Conversation, Einstein Institute for Science, Health and the Courts. Hawaii, June/July 2001. 69. Participant as Expert, Hearing on the ACHR Special Report on Genomics and Health. Geneva, Switzerland, June 2001. 70. Participant as Regional Representative, Joint WHO-Thai Health Research Forum Multi-Regional Consultative Meeting on Genomics and Health (part of the process for preparing a WHO-ACHR (Advisory Committee on Health Research report on this topic). Bangkok, Thailand, July 2001. 71. International Forum on Transplant Ethics. Quebec, Canada, July 12-15, 2001. 49
    • Curriculum Vitae, Daar AS 72. African Centre for Technology Studies. Nairobi, Kenya, August 2001. Planning of Genomics Executive Course, with Rotman School of Management, University of Toronto. 73. Conference on Globalization and Biotechnology: Ethical Considerations. Harvard University. Cambridge, Massachusetts, USA, September 2001. 74. Congress of the Asian Society of Transplantation. New Delhi, November 2001. 75. Bioethics Seminar, University of Toronto Joint Centre for Bioethics. Toronto, Ontario, Canada, November 2001. 76. Einstein Institute for Science, Health and the Courts (EINSHAC) meeting in Hawaii July 2001. 77. WHO conference on biotechnology, Cuba, 20-22, March 2002 Presented a paper on capacity strengthening and opinion leader networs. 78. Public Forum on Stem Cells, Human Therapeutic Cloning, and Regenerative Medicine. JCB Jan. 30, 2002. 79. Executive development course on genomices and health policy, held in nairobi together with the African Centre for Technoly Studies. March 2002. See www.geneticsethics.org 80. WHO meeting on collaboration for genetic services , Toronto, April 2002 Presented a paper on “Harnessing Genomics and Biotechnology for Developing Countries.” April 9-10, 2002. 81. International Forum on Transplant Ethics. Montreal, April 2002. 82. Human Genome Organization Ethics Committee meeting , Shanghai, China, April, 2002. 83. Executive Course at Rotman School of Management. Genomics Policy. May 2002. 84. Public Health Ethics conference U of Toronto, May 2002. lecture entitled “ Challenging health inequities: a global perspective”. 85. Einstein Institute for Science, Health and the Courts/ and National judicial Institute if Canada. Ottawa, Ontario, Canada, June 2002. 86. Government of Canada’s Policy Research Initiative Symposium on Genomics and Public Policy. June 6-8, Toronto Marriot Eaton Centre. 87. California Endowment/Rockefeller Foundation Conference on Technology, Health and Philanthropy, june 26-28 2002, Ritz Carlton Hotel, Half Moon Bay , California. Preseneted a paper on biotechnologies for developing countries. 88. (International)Transplantation Society – International Conference. Miami, Florida. August 2002. Lecture entitled: “The Science of Stem Cells: Some Implications for Law and Policy.” 89. Pan American Health Association/WHO. Brasilia, Brazil. October 2002. Global Forum on Research Bioethics-International Guidelines: Genomics and Global Health. 50
    • Curriculum Vitae, Daar AS 90. Arizona Biomedical Institute. Phoenix, Arizona. November 2002. Developing Ethical Guidelines for Plant-Made Vaccines. 91. CIHR Think-Tank on Knowledge Translation, Oct 2002. 92. Stem Cells: Scientific Potential, Ethical Controversy. October 11, 2002. Taped for TVO to be shown in Dec 2002. 93. Toronto May 2002. Talk entitled “Challenging Inequities in Health: A Global Perspective”. 94. Victoria, BC and Ottawa to educate senior judges on genomics/biotech issues with the Canadian National Judicial Institute (NJI) and the US Einstein Institute for Science, Health and the Courts. Montreal in September 2002. 95. Institute for the Future, on “New Consumer, New Genetics”, Berkeley, Ca in preparation of our work on nutrigenomics. 96. Addressed a joint meeting of the Boards of the Rockefeller Foundation and the California Endowment, Half Moon Bay, Ca on future biotechnologies for health. 97. Participated in an international conference on Public Health Ethics, organized with the International Assoc. of Bioethics, Abu Dhabi, March 2002. 98. “International Conference on Post-Market Surveillance of Genetically Modified Foods: Issues, Challenges and Opportunities” in Ottawa October 16-17, 2002. 99. “Key Market Drivers for the Nutrigenomics Market: Bioethics, Regulations, and Consumers”. Cupertino, California. November 2003. 100.Third GCC Conference of Faculties of Medicine on Medical Education. December 16- 18, 2002. Sultan Qaboos University, College of Medicine, Oman. 101.International Conference on Post-Market Surveillance of Genetically Modified Foods: Issues, Challenges and Opportunities. Ottawa, Canada, October16-17, 2002. 102.Genome Policy Course, Kochi , India, Jan 2003. 103.Genome Canada winter symposium in Montreal, Feb 2003. 104.CIHR/NRC and NSERC “NanoHealth/Nanomedicine Workshop: Establishing An Innovative Research Agenda for Canada”. Montreal, February 2003. 105.Public Health Sciences Research Day. “Global Public Health”. University of Toronto. February 28, 2003. 106.Rockefeller Foundation. Capetown, South Africa. African Working Group (1) Innovation Working Group, (2) Joint Learning Executive on Human Resources for Health Care. March 2003. 51
    • Curriculum Vitae, Daar AS 107.CIHR Workshop On: “Regenerative Medicine: Defining the National Strategy for Tissue Engineering and Artificial Organs”. March 16-17 2003. 108.European Akademie Bioethics in a small world. Bonn in April 2003. Talk on Beyond GM Foods: Genomics, Bioethics and Global Health Equity. 109.Addressed a joint meeting of the Boards of the Rockefeller Foundation and the California Endowment, Half Moon Bay, Ca on future biotechnologies for health. 110.29th Gallie Day. Department of Surgery, University of Toronto, May 8-9, 2003. 111.Canadian Museum of Nature. “Bridging Troubled Waters: Canada’s Role in Connecting Biotechnology to Global Human Needs”. Ottawa, Canada. June 2003. 112.Institute on Governance. Ottawa, Ontario. “Opportunities: Why Biotechnology Matters to Developing Countries and Why It Should Matter To Us”. June 2003. 113.Institute of Medicine of the National Academies of Sciences. “Bioethics, Genomics, and Public Health”. Washington D.C., June 2003. 114.Gave a talk entitled “Nanotechnology: An Ethical Perspective.” to students in the Faculty of Materials Science and Engineering, University of Toronto, Jul 25th, 2003. 115.Aga Khan Health Board for the United States of America. Isamaili Health Professionals Association. Symposium 2003. Atlanta, Georgia. 116.8th Cast Congress of the Asian Society of Transplantation. 23-27 September 2003 Kuala Lumpur Malaysia. 117.World Health Organization. “Ethics, access and safety in tissue and organ transplantation: Issues of global concern”. Madrid, Spain, 6-9 October 2003. 118.Ethics Advisory Committee Pilot. North Carolina, August 27-28 2003. 119.Government of Canada Discussion Session on: “Nanotechnology: Policy Implications Arising from Health, Environmental and Other Issues”. November 14, 2003. NRC Auditorium, Ottawa. 120.Oxford Vision 2020, University of Oxford, England. December 2003. 121.Presented a talk in Oman to the Young President’s Organization on “Technology, Waves and Futures.” December, 2003. 122.Government. Of Canada Biotechnology Conference. Biotechnology, Canada & International Development: The Public Policy Implications. Government Conference Centre, Ottawa, January 19th 2004. Gave a talk on: “Top 10 Biotechnologies and Millennium Development Goals.” 52
    • Curriculum Vitae, Daar AS 123.Gave a lecture In Saudi Arabia on “Technology and Choice in the 21st Century, King Faisal University, Dammam Saudi Arabia, February, 2004. 124.Attended a conference in Ditchley, England, February 12-14, 2004. The topic was “Biogenetics: The Impact of Advances on Politics and Society.” 125.Participated On A Scientific Roundtable on Arsenic Water Pollution in Montreal, March 8, 126.Inaugural Lecture on Evolution of Genomics. The Bourns Lecture in Bioethics. McMaster University, March 2004. 127.Participated in the Joint Learning Initiative Working Group on Innovation Meeting in Barcelona, March 11 & 12, 2004. Presented a paper on Diaspora Options. 128.Priority Setting in Genomics. Presented a paper on Genomics and Global Health. Norway. September 2004. 129.Advancing Technologies: Surveying the Global Capacity For Research, Development, And Application. Policy And Global Affairs Division/National Research Council .The Board on Global Health/ Institute Of Medicine. The US National Academies. Committee on Advances In Technology And The Prevention Of Their Application To Next Generation Bioterrorism And Biological Warfare Threats. Presented a paper on Technology for Development vs. Next Generation Threats: Applying the Human Security Lens. Instituto Nacional Salud Publica. Cuernavaca, Mexico. September 21-22, 2004 130.International Congress of the Transplantation Society. Vienna, September 2004. Presented a symposium on Replacement vs. Regenerative Strategies. 131.The Executive Course on Genomics and Public Health Policy. Latin America and the Caribbean. Developed course in conjunction with the Canadian Program on Genomics and Global Health. May 2004. 132.The Executive Course on Genomics and Public Health Policy. Hong Kong, China. Developed course in conjunction with the Canadian Program on Genomics and Global Health. October 2004. 133.Intellectual Property Modeling Group. Florence, Italy. Participated in developing relational/ influence maps. October 2004. 134.Robert Schuman Centre for Advanced Studies European University Institute, Florence, Italy. European Forum Series on the Role of Universities in Innovation Systems. Presented a paper and symposium on Harnessing Genomics for Global Health: the Role of Higher Education. October 26, 2004. 135.Cultures of Innovation Workshop. Lemelson Center for the Study of Invention and Innovation, Washington, DC. May 2005. Presentation on Biotechnology Innovation. 136.Videoconference: “Biotechnology, Genetics, Bioethics and its implications in Public Health”. University of Chile, Centre of Interdisciplinary Studies in Bioethics. July 14, 2005. 53
    • Curriculum Vitae, Daar AS 137.African Panel on Biotechnology. Johannesburg, South Africa. August 8-9, 2005. 138.Eurotransplant International Foundation Conference. Organ Donation, Procurement, Allocation and Transplantation in a Globalized World – Lessons from Different Cultures. Munich, Germany. September 9, 2005. Invited to give a presentation on subject: “Do Western ethical guidelines apply globally?” 139.2005-2006 Canadian Research Chair in Law and Medicine Conference Series. Montreal, Canada. October 5, 2005. Invited to give a presentation on Regenerative Medicine. 140.Workshop: International Perspective on Pharmacogenetics: The Intersections Between Innovation, Regulation and Health Delivery. Rome, Italy. October 17-19, 2005. 141.Fourth Scientific Conference for Medical Students in the GCC Countries. January 21-24, 2006. Invited as Keynote Speaker. 142.Fourth International DNA Sampling Conference: Genomics and Public Health. Montreal, Canada. June 4-7, 2006. Invited to Chair during “Public Health Genomics: The Role of International Stakeholders”. 143.Assisting States to Effectively Fulfill UNSCR 1540’s Legal Reguirements: Workshop. New York, USA. November 15, 2005. Invited Speaker. 144.The Global Bargain for Biosecurity: Worshop. New York, USA. November 16-17, 2005. Invited Speaker – “Biotechnology for Development”. 145.Grand Challenges in Global Health Kick Off Meeting. Focus Groups on Ethical, Social, Cultural Issues. November 18-23, 2005. 146.9th Congress of Asian Society of Transplantation and 5th International Symposium of Urology, Nephrology and Transplantation (SIUT). Karachi, Pakistan. November 29-December 4, 2005. Invited Chairperson and Speaker – “Regenerative Medicine and the Developing World”. 147.Genomics and Population Health Conference. London, UK. January 26, 2006. Invited Speaker – “Genomics and Global Public Health”. 148.Health Law Institute Seminar Series. Ottawa, Canada. February 28, 2006. Invited Speaker – “Whither Regenerative Medicine: Science, Ethics and Politics”. 149.2006. NRC Latin America Vaccines in Human Workshop. Ottawa. March 8, 2006. Panel Chair – “Fostering Health Biotechnology Innovation in Developing Countries- The Case of Latin America”. 150.2006. Rockefeller Foundation. New York. March 10, 2006. Invited Speaker. Life Sciences and Global Health 151.McMaster University Bournes Lecture. Hamilton, Canada. March 29, 2006. Inaugural Endowed Lecture – “The Life Sciences and Global Health”. 54
    • Curriculum Vitae, Daar AS 152.2006 World Summit on Innovation and Entrepreneurship. Muscat, Oman. April 1-3, 2006. Invited Speaker. 153.2006. Joint Coordinating Board of TDR. Accra, Ghana. June 2006. Presentation (as Chair of the Review Committee) of the 4th External Review of TDR. 154.2006. 32nd Gallie Day, Dept of Surgery, University of Toronto . Gallie-Bateman Presentation. “Nanotechnology and the Developing World” 152.2006. The National Institute of Genomic Medicine and the School of Philosophy of the National University Autonomous of Mexico (INMEGEN). Aug 24, 2006. International Forum ‘Bioethics and Global Health’. “Pharmacogenomics and geographical ancestry: Implications for the development of drugs and global health” 153.September 2006. Royal Society, London. Invited Panelist and Rapporteur. RS-ICSU-IAP Worshop on Scientific and Technological Developments Relevant to the Biological and Toxins Weapons Conventions (BTWC). 154.September 2006. Kyoto, Japan. Science and Technology in Society Forum. Invited Lecture on “Enhancing Food Security by Science” 155.September 27-28, 2006. External Advisory Board and launch of the McLaughlin Rotman Centre for Global Health 156.October 3, 2006. Ethical, Social and Cultural Issues Program for The Grand Challenges In Global Health 2006. Grand Challenge #9 meeting. Washington, DC. 157.October 4-6, 2006. Annual meeting of the Grand Challenges in Global Health program. Washington DC. 158.October 2006. Iranian Academy of Medical Sciences. Invited Lecture: “Regenerative Medicine: The Next Frontier.” 159.October 28, 2006. Iranian Academy of Medical Sciences. Series of Lectures related to the UNESCO Avicenna Prize. 1. Plenary Session, UNESCO First Sub-Regional Expert Meeting on Ethics Education in Science and Technology. “Overview of Science and Technology Ethics” 2. Tehran University of Medical Sciences, "Bioethics: a new paradigm" 3. Shehid Beheshti University, Tehran. Speech on “Ethics of Science and Technology” at the ceremony to celebrate the Avicenna Prize. Also given at 4. National Research Center for Genetic Engineering and Biotechnology, ceremony in honour of the Avicenna Prize. 160. 29 October, 2006. Iranian Academy of Medical Sciences. Plenary Session, UNESCO Subregional Expert Meeting on Ethics Education in Science and Technology "Rethinking Ethics in the Context of Science and Technology for Global Health: The Role of Emprical, Qualitative Research", Subregional Expert Meeting on Ethics Education in Science and Technology 55
    • Curriculum Vitae, Daar AS 161. November 2, 2006. “Harnessing Pharmacogenomics for Global Health”. International Symposium. Grand Rounds in Population Pharmacogenomics. Organized by FDA. White Oak, CSU. USA 162.November 2006. Muscat, Oman. Expert Meeting of the Division of Ethics of Science and Technology. “Ethics Teaching and Scholarship: Expanding Our Horizons”. 163.January 29, 2007. Massey College. University of Toronto. Science and Medicine Roundtable. “The shortage of organs for human transplantation: Should we be paying donors? 164.March 16, 2007. Young Presidents Organization. Middle East and North America (MENA) Chapter Conference. “Trendspotting: Science, Power and Development” 165.April 14, 2007. Stanford Medical Centre. Unite for Sight Conference. “Life Sciences and Health in Africa” 166.May 27, 2007. McLaughlin Centre for Molecular Medicine. Annual Retreat. May 27-28, 2007 Langdon Hall, Cambridge. “Getting the science to where it is needed: The translational role of the MCMM Ethics and Policy Program”. 167.May 21, 2007. Human Genome Organization Ethics Committee, Montréal. 168.June 4-5, 2007. Intellectual Property Modeling Group, Florence. Unpacking Access: Towards the Practical Implementation of Biotechnology. Facilitated discussion on Access to agricultural and health-related knowledge. 169.June 4-6,2007. Gates Foundation Grand Challenges in Global Health. Scientific Progress Meeting, Lugano, Switzerland. Grand Challenge 4: Devise Reliable Testing Systems for New Vaccines. 170.June 11, 2007. The Lupina Centre for Health Care, Spirituality and Ethics, Regis College, University of Toronto. Visioning Meeting. 171.June 13-14, 2007. Immunization Technologies Strategy Working Group (ITSWG Colorado. ESC Program of Grand Challenges in Global Health and Vaccines Working Group. 172.September 4-5, 2007. “Priorities in Global Health – What should the UN University International Institute for Global Healht Focus on?”. UNU-IIGH. Kuala Lumpur, Malaysia. 173.September 2007. Institute for the Study of Muslim Civilizations, London, September, 2007 174.October 2007. “Life Sciences Innovation and Convergence in Africa”. Gates Foundation Grand Challenges in Global Health Annual Meeting, Cape Town. 175.October 23-24, 2007. “Conducting the Delphi Study on GC CNCDs”. Executive Committee of Grand Challenges in CNCDs. Oxford Health Alliance. United Kingdom. 176. October 23-24, 2007. “Grand Challenges in Non-Communicable Diseases” Executive Committee and Scientific Board Meeting. United Kingdom. 56
    • Curriculum Vitae, Daar AS 177.October 25-29, 2007. “Mars Africa Proposal – Proposal for Convergence Facilities in Sub- Saharan Africa”. Presentation to the African Development Bank and the Bill and Melinda Gates Foundation. Tunis, Tunisia. 178.November 5, 2007 – “Life Sciences and Global Health-_ Exploring the Role of Engineers in a Helical World”. University of Toronto Biomedical Engineering Class. 179.November 15, 2007. “ Life Sciences, Innovation and Convergence Mechanisms in Sub-Saharan Africa”. Bill and Melinda Gates Foundation. Seattle, Washington. USA 180.November 30, 2007. “Convergence Innovation in Sub-Saharan Africa”. Ministry of Science and Technology – Kigali, Republic of Rwanda. 181.December 14, 2007. “Harnessing Pharmacogenomics for Global Health”. Indo-French Symposium (Senior Scientists). Pharmacogenomics: concepts, technology, clinical relevance and ethical aspects. Kochi (Cochin), India. 182.January 21, 2008. “Genomics, Bioethics and Public Policy”. Graduate Course CHL5121 Lecture to University of Toronto students at the Program on Life Sciences, Ethics and Policy. Toronto. Canada 183.February 4-5, 2008. 1) “Grand Challenges in Chronic Non-Communicable Diseases: NIH’s Role’. Address to the Fogarty International Centre and National Institutes of Health. Washington. USA 2) Address to the Fogarty International Centre Council: Grand Challenges in Chronic Non-communicable Diseases in Fogarty's strategic plan. 184.February 11, 2008. " Reflecting on RMEthNet". RMEThNet 3rd Annual General Meeting. McLaughlin-Rotman Centre for Global Health, Toronto, Canada 185.February 13, 2008. “"Grand challenges in global health ESC working groups, with special focus on the vaccine delivery technology Working Group”. Vaccine and Technology Consortium. Medicine in Need. Paris, France. 186.February 25-27, 2008. “Grand Challenges in Chronic Non-Communicable Diseases’. 2008 Oxford Health Alliance Annual Summit ‘Building a Healthy Future: Chronic Disease and our Environment’. Sydney, Australia. 187.April 22-24, 2008. “What Ails the World? How do we respond? Keynote Speaker at 13th Health Sciences Conference. Kuwait University, Kuwait. 188.April 2008. “Global Health Ethics”. Keynote Speaker at the International Ethics Conference. Tehran. Iran 189.April 2008. “Grand Challenges in Non-Communicable Diseases”. Biovision Alexandria 2008. Alexandria, Egypt. 190.April 14, 2008. “Lessons from Health Biotechnology Innovation Systems of Emerging Economies”. Special Session on Problems Hindering Biotechnology Research in the Arab 57
    • Curriculum Vitae, Daar AS Region: Lessons Learned and Possible Solutions. Biovision Alexandria 2008. Alexandria, Egypt 191.May 20-25 2008. “Large Scale Genotyping Projects in Developing Countries and Emerging Economies”. Food and Drug Administration. Mexico 192.17-20 June, 2008. “Large Scale Genotyping Projects in Developing Countries: Future Opportunities”. Global Health. Session Chair. Bio 2008 Convention. San Diego. 193.May 21-23. Mexico City. Conference organized with Mexican Institute of Genomic Medicine and the US Food and Drug Administration. Emerging Regulatory Issues in Genomic Medicine. Conference Summary: Developing World Lens. 194.Chautauqua Institution, NY, USA July 19, 2008: “Global Health Ethics: Weaving a Single Garment of Destiny” July 29, 2008: “Building Global Health: The Social Architecture”. This lecture can be seen online at FORA.tv - Abdallah Daar: Building Global Health <http://fora.tv/2008/07/29/Abdallah_Daar_Building_Global_Health> Abdallah Daar discusses issues of global health and the social and political architecture necessary for solving global health problems as a part of the ... 195. Global Ministerial Forum on Research For Health, Bamako, Mali, November 2008 i. Scenario planning for 2005: Chronic Non-communicable Diseases ii. Intellectual Property iii. Technology Innovation E. COURSES TAUGHT at University of Toronto Courses • Developed a new course, CHL5121H, entitled Genomics, Bioethics, and Public Policy (2004-) • With Ann Robertson and Ross Upshur, developed and delivered a new course on Public Health Ethics • Participated in training of MHSc in bioethics fellows (more than 20 overseas fellows so far from Ghana, India, Nigeria, Pakistan, Uganda, Chile, South Africa, etc, funded by the NIH/Fogarty International Centre; and some funded by WHO/Eastern Mediterranean Region (from Spain, Iran); plus 41 domestic MHSc Students. • Organized and directed seven Executive courses on Genomics and Public Health Policy: 1&2. Toronto in May 2002 and 2003; 3. Africa, with the African Centre for Technology Studies 2002 (about 11 countries participated); 4. With the Indian Council for Medical Research, India; 5. With WHO/Eastern Mediterranean Regional Office held in Oman in September 2003 (about 13 countries participated); 6.With PAHO and United Nations University, for the Latin America and Caribbean Region, held in Caracas in May 2004 (almost all Latin American countries participated plus two Caribbean countries); and 7 with the University of Hong Kong 58
    • Curriculum Vitae, Daar AS for the Western Pacific and South East Asian regions October 20-24 in Hong Kong (about 9 countries participated). • Also teaching in the following courses: o MHSc 3001Y, Foundation Seminar I o MSc 30016Y, Independent Study o MSc 1052H, Clinical Bioethics o MSc 7000Y CIHR Course in Regenerative Medicine ----------------------- Errors and Omissions Expected Dates are approximate 59